Microenvironment viscosity-sensitive fluorescent dye as well as preparation method and application thereof
By developing a microenvironment viscosity-sensitive fluorescent dye, the problems of high background fluorescence, short wavelength, and poor photostability of existing fluorescent dyes in live cell imaging have been solved. This results in low background fluorescence, long wavelength emission, and good photostability, making it suitable for long-term dynamic tracking and live cell imaging.
Patent Information
- Application Number
- CN202310513329.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2023-05-09
- Publication Date
- 2024-11-12
AI Technical Summary
Existing fluorescent dyes have high background fluorescence, short wavelength, poor tissue penetration, and insufficient photostability and fluorescence lifetime in live cell imaging, making it difficult to achieve long-term dynamic tracking and live imaging.
To develop a microenvironment viscosity-sensitive fluorescent dye that activates fluorescence in high viscosity environments, exhibits long-wavelength emission, good photostability, and a long fluorescence lifetime, modulates fluorescence intensity through viscosity responsiveness, and can specifically label biological substances by covalent or non-covalent binding.
It achieves low background fluorescence, long wavelength emission, good photostability and long fluorescence lifetime, making it suitable for long-term dynamic tracking and in vivo imaging. It can specifically label intracellular biological substances and perform multicolor labeling imaging.
Smart Images

Figure CN118930573A_ABST
Abstract
Description
Technical field:
[0001] The invention relates to a microenvironment viscosity-sensitive fluorescent dye and a preparation method and application thereof. Background technology:
[0002] Fluorescence imaging-based technology has become an indispensable tool for biomedical research, and the development of fluorescent dyes has become an important part of chemical biology. Among them, the development of small molecule fluorescent dyes is particularly important because of their small molecular structure, rapid penetration of cell membranes, high sensitivity and fast response time, which are more advantageous than fluorescent protein-based probes in optical imaging and analytical sensing. At present, fluorescent dyes have been widely used in cell staining, construction of environmental sensors, and fluorescent labeling of biomolecules. Therefore, a large number of fluorescent dyes have been developed in the past few decades. Most of these fluorescent dyes are based on the classic dye "mother core" (such as coumarin, fluorescein, BODIPY or cyanine) (LD Lavis, ACS Chem. Biol. 2008, 3, 3, 142–155; LD Lavis, ACS Chem. Biol., 2014, 9, 855-866.), but most of them are always bright fluorescent dyes, which have high background fluorescence when performing fluorescence imaging in living cells. In addition, most fluorescent dyes developed based on these classic mother nuclei have short wavelengths and poor tissue penetration. Among them, although cyanine dyes have longer wavelengths, they have poor biological stability and are therefore difficult to apply to in vivo fluorescence imaging.
[0003] In response to the problem of high background fluorescence of current fluorescent dyes, activated fluorescent dyes came into being (H. Tian, Chem. Soc. Rev., 2019, 48, 683-722. W. Huang, Chem. Soc. Rev., 2022, DOI: 10.1039 / d2cs00562j.). In principle, they do not fluoresce or fluoresce weakly before binding to the target substance, and the fluorescence lights up or significantly enhances after binding to the target substance. There are two main types of activated fluorescent dyes that are currently used: quenching group-modified ever-bright fluorescent dyes and environmentally sensitive fluorescent dyes. Quenching group-modified ever-bright fluorescent dyes refer to compounds formed by covalently binding ever-bright fluorescent dyes such as coumarin, fluorescein and rhodamine to a quenching group through a connecting chain (A. Jaschke, Angew. Chem. Int. Ed. Engl., 2013, 52, 13401-13404.). Among them, the fluorescence of the dye molecule is quenched by the FRET or PET effect between the dye molecule and the quenching group; when this compound binds to the target molecule to be measured, the energy transfer effect is destroyed and the fluorescence is restored. Environmentally sensitive fluorescent dyes refer to fluorescent dyes whose fluorescence changes with the different microenvironments in which the dye molecules are located. They are divided into fluorescent dyes with solvation effects and viscosity-sensitive fluorescent dyes (M. Ryckelynck, Int. J. Mol. Sci., 2017, 19.). Environmentally sensitive dye molecules have attracted much attention because they have smaller molecular structures, lower background fluorescence and higher sensitivity than the ever-bright fluorescent dyes modified with quenching groups.
[0004] Although various environmentally sensitive fluorescent dyes have been developed, such as CCVJ, HBI and thioflavin T (B. Shen, J Mater Chem B, 2020, 8, 9642-9651; G.-i. Konishi, Journal of Materials Chemistry C, 2016, 4, 2731-2743.), their emission wavelength is short and their photostability is poor, making it difficult to apply them to long-term dynamic tracking at the cellular level, and even more difficult to achieve in vivo fluorescence imaging. Therefore, it is crucial to develop environmentally sensitive fluorescent dyes with long emission wavelengths, good photostability and low background fluorescence. At present, there have been some breakthroughs in the development of long-wavelength environmentally sensitive fluorescent dyes, with the longest emission wavelength reaching 700nm (Z. Nie, J. Am. Chem. Soc., 2021, DOI: 10.1021 / jacs.1c04577.), but the excitation wavelengths of these fluorescent dyes are short, making it difficult to achieve red light excitation and red light emission. This means that although these molecules can achieve long-wavelength emission, they still cannot avoid the interference of in vivo autofluorescence (background fluorescence) caused by short-wavelength excitation. In addition, these dyes have poor photostability and low fluorescence quantum yield, and are not suitable for long-term tracking and in vivo imaging of biological substances. Therefore, it is of great significance to develop environmentally sensitive fluorescent dyes with long excitation and long emission wavelengths, good photostability, and high fluorescence quantum yield.
[0005] In addition, based on the fact that the fluorescence lifetime of fluorescent dyes is only related to their own structure and the microenvironment in which they are located (such as polarity, viscosity and other conditions), and has nothing to do with laser intensity or whether or not light is quenched (K.Suhling, J.Am.Chem.Soc.2008,130,21,6672-6673), fluorescence lifetime is a more accurate means of indicating the structure of biomolecules or the interaction between biomolecules. In principle, for environmentally sensitive dye molecules, their fluorescence lifetime can directly reflect the microenvironment in which the dye is located. However, the fluorescence lifetime of currently developed environmentally sensitive fluorescent dye molecules is generally short, and is only about 1ns in the microenvironment with the longest fluorescence lifetime. With such a low fluorescence lifetime, it is difficult for ordinary instruments to achieve accurate detection. Therefore, if environmentally sensitive fluorescent dyes with longer fluorescence lifetimes can be developed, it will provide necessary tools for accurate in vivo and in vitro imaging and detection of biological substances. Summary of the invention:
[0006] The fluorescent dye molecules of the present invention do not fluoresce in a free state, but can activate fluorescence under a microenvironment with a high viscosity such as glycerol. This is a brand-new microenvironment viscosity-sensitive fluorescent dye, and this type of dye has obvious viscosity responsiveness, and its fluorescence intensity changes with the viscosity of the microenvironment, and the higher the viscosity, the stronger the fluorescence intensity. In addition, this type of dye molecule has a longer emission wavelength and fluorescence brightness, and can maintain good light stability under the excitation conditions of high laser intensity, and is not prone to photobleaching, meeting the needs of long-term monitoring of biological substances in vivo and in vitro and its in vitro detection. In addition, this type of dye molecule has a longer fluorescence lifetime, and the fluorescence lifetime changes with the changes in the microenvironment in which the dye is located, and the structure and interaction of biological substances can be studied by monitoring the changes in the fluorescence lifetime.
[0007] Specifically, the present invention provides a fluorescent dye having a structure as shown in formula (I),
[0008]
[0009] in:
[0010] A is -N(X1)(X2) or HO-, B is =N + (X3)(X4) or =O, or X1, X2 and R2 and / or R3, or X3, X4 and R4 and / or R5 are connected to form a heterocyclic group;
[0011] X1, X2, X3, and X4 are each independently selected from at least one of hydrogen, alkyl, modified alkyl, aryl, heteroaryl, and unsaturated or saturated heterocyclic groups, or X1 and X2, or X3 and X4 are optionally connected to each other to form a saturated or unsaturated unsubstituted or R 1-1 substituted heterocyclic group or heteroaromatic ring, or X1, X2 and R2 and / or R3, or X3, X4 and R4 and / or R5 are optionally connected to each other to form a saturated or unsaturated unsubstituted or R 1-1 substituted heterocyclic group;
[0012] and / or R1, R2, R3, R4, R5, R6 are optionally independently selected from hydrogen, a halogen atom, a nitro group, or an alkyl group;
[0013] When K is selected from S, Se, Te, Te=O, unsubstituted or 1 or 2 R 1-1 Substituted carbon, unsubstituted or 1 or 2 R 1-1 Substituted germanium, (R0 are each independently selected from ), G is selected from the following formula (I-1-1), formula (I-1-2), formula (I-1-3) or (I-1-4);
[0014] When K is selected from O or unsubstituted or 1 or 2 R 1-1When the silicon is substituted and A is not -N(X1)(X2), G is selected from the following formula (I-1-1), formula (I-1-2), formula (I-1-3) or formula (I-1-4).
[0015] When K is selected from O or unsubstituted or 1 or 2 R 1-1 Substituted silicon, when A is -N(X1)(X2) and B is =N+(X3)(X4), G is selected from the following formula (I-1-2) or formula (I-1-3);
[0016]
[0017] in,
[0018] Each R 1-1 Each is independently selected from a halogen atom or an alkyl group;
[0019] Each Y is independently selected from O, S, NH, Se, or Te;
[0020] Each Z is independently selected from C, or N,
[0021] Each R a , each R b , each R c Each is independently selected from hydrogen, sulfonic acid group, haloacyl group, cyano group, cyanate group, isothiocyanate group, carboxyl group, ester group, amide group, nitro group, halogen atom, alkyl group, haloalkyl group, modified alkyl group;
[0022] The C ring in formula (I-1-2) and the E ring in formula (I-1-3) are each independently selected from at least one of an aromatic ring or an aromatic heterocyclic ring;
[0023] Each hydrogen atom in formula (I-1-2) and formula (I-1-3) is optionally independently substituted by a halogen atom or an alkyl group;
[0024] D in formula (I-1-2) and F in formula (I-1-3) are each independently selected from hydrogen, cyano, amino, isothiocyanate, carboxyl, sulfone, phosphite, ester, amide, nitro, halogen, alkyl, aryl, heteroaryl, or modified alkyl;
[0025] in,
[0026] The "alkyl" is C1-C 10Straight or branched alkyl; preferably, C1-C7 straight or branched alkyl; preferably, C1-C5 straight or branched alkyl; preferably, selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, isopentyl, 1-ethylpropyl, neopentyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl ... hexyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3-dimethylbutyl, 2-ethylbutyl, n-heptyl, 2-methylhexyl, 3-methylhexyl, 2,2-dimethylpentyl, 3,3-dimethylpentyl, 2,3-dimethylpentyl, 2,4-dimethylpentyl, 3-ethylpentyl or 2,2,3-trimethylbutyl;
[0027] The "modified alkyl" is a group obtained by replacing any carbon atom of an alkyl group with at least one group selected from a halogen atom, -O-, -OH, -CO-, -NO2, -CN, -S-, -SO2-, -(S=O)-, an aryl group optionally substituted with a halogen atom, an amino group, a secondary amino group, a tertiary amino group, a heterocyclic group, a saturated or unsaturated monocyclic or heterocyclic group, and the modified alkyl group has 1 to 30 carbon atoms (preferably 1 to 20 carbon atoms, more preferably within 10 carbon atoms), and its carbon-carbon single bond is optionally independently replaced by a carbon-carbon double bond or a carbon-carbon triple bond;
[0028] The carbon atom is replaced, which means that the carbon atom or the carbon atom together with the hydrogen atoms thereon are replaced by the corresponding group;
[0029] The "heterocyclic group" is a 4-10 membered monocyclic or polycyclic heterocyclic group containing at least one heteroatom selected from N, O, S or Si in the ring;
[0030] The "aryl" or "aromatic ring" is a 5-10 membered monocyclic or fused bicyclic aromatic group;
[0031] The "heteroaryl" or "aromatic heterocycle" is a 5-10 membered monocyclic or fused bicyclic heteroaromatic group containing at least one heteroatom selected from N, O, S or Si in the ring;
[0032] The halogen atoms in the "halogen atom", "haloalkyl", "haloacyl" and "aryl substituted with halogen" are each independently selected from F, Cl, Br and I;
[0033] The "ester group" is -(C=O)OR 1-2 Group;
[0034] The "amide group" is -CONR 1-2 Group;
[0035] The "sulfone group" is -SO2R 1-2 Group;
[0036] The "sulfoxide"-SOR 1-2 Group;
[0037] The "secondary amino group" is -NHR 1-2 Group;
[0038] The "tertiary amino group" is -NR 1-2 R 1-3 Group;
[0039] Each R 1-2 , R 1-3 Each is independently H, an alkyl group, a modified alkyl group or a halogen atom.
[0040] Optionally, among the above fluorescent dyes,
[0041] X1, X2 and R2 and / or R3 are optionally connected to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formula:
[0042]
[0043] X3, X4 and R4 and / or R5 are optionally connected to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formula:
[0044]
[0045] Preferably, the heterocyclic group formed by X1, X2 and R2 and / or R3 or X3, X4 and R4 and / or R5 is a symmetrical structure;
[0046] Preferably, each R' is independently selected from hydrogen or alkyl;
[0047] Preferably, X1 and X2 are optionally connected to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formulae, wherein the following groups are optionally substituted by halogen atoms;
[0048]
[0049] Preferably, X3 and X4 are optionally connected to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formulae, wherein the following groups are optionally substituted by halogen atoms;
[0050]
[0051] Preferably, the heterocyclic group composed of X1 and X2, X3 and X4 is a symmetrical structure;
[0052] Preferably, K is selected from oxygen, sulfur, selenium, tellurium or the following groups:
[0053] Optionally, among the above fluorescent dyes,
[0054]
[0055] Preferably, formula (I-1-1) and (I-1-4) are selected from any of the following groups:
[0056]
[0057] Preferably, formula (I-1-2) can be selected from any of the following groups:
[0058]
[0059]
[0060] Alternatively, formula (I-1-3) may be selected from any of the following groups:
[0061]
[0062]
[0063] Optionally, the fluorescent dye represented by formula (I) of the present invention is selected from the following compounds:
[0064]
[0065]
[0066]
[0067]
[0068]
[0069]
[0070]
[0071]
[0072] The viscosity responsiveness of the fluorescent dye mentioned above means that the fluorescence intensity of the dye molecule responds to the viscosity of the solution, and the fluorescence intensity increases as the viscosity of the solution increases. Optionally, the viscosity responsive fluorescent dye is an organic dye molecule whose maximum fluorescence emission intensity in glycerol and in methanol is greater than 10, preferably greater than 100, and more preferably greater than 1000 at 25°C and under the conditions of equal concentration and excitation wavelength. The concentration range of the viscosity responsive dye is 1×10 -7 M-1×10-5 M.
[0073] The fluorescent dye has an adjustable structure and a long fluorescence emission wavelength, which can reach up to 900 nm. The operator can select dyes of different types or emission / excitation wavelengths as needed.
[0074] The fluorescence intensity of the fluorescent dye increases with the increase of the environmental viscosity, and the fluorescent dye is sensitive to the viscosity and has viscosity responsiveness.
[0075] The above fluorescent dyes have excellent photostability and are not easily photobleached under laser irradiation, and can be used for long-term dynamic tracking of target molecules.
[0076] The above fluorescent dyes can be used for specific labeling of target substances such as proteins or nucleic acids. After the fluorescent dyes bind to the target substances, the fluorescence can be activated. They have good fluorescent molecular switch properties, high fluorescence activation multiples, and high fluorescence activation brightness.
[0077] The above fluorescent dyes label the analytes very quickly.
[0078] The fluorescence intensity of the fluorescent dye has a good linear relationship with the concentration of the analyte, and can be used for quantitative detection of the analyte, which includes but is not limited to proteins, nucleic acids and metabolic molecules.
[0079] The above fluorescent dyes can specifically label biological substances in cells and achieve specific fluorescence lighting. At the same time, the probe fluorescence is not affected by the intracellular environment.
[0080] The above fluorescent dyes can be used as powerful tools for labeling cellular subcellular organelles, such as the nucleus, mitochondria, Golgi apparatus, endoplasmic reticulum, whole cells, cytoskeleton, extracellular membrane, lysosome, intracellular membrane, etc.
[0081] The spectra of the fluorescent groups of the above fluorescent dyes will not interfere with each other. The fluorescent dyes of different color systems of the present invention can perform multi-color labeling on samples and can perform orthogonal labeling imaging at the same time.
[0082] The fluorescent dyes mentioned above have a long fluorescence lifetime, and the fluorescence lifetime changes with changes in the microenvironment in which the dyes are located.
[0083] In a second aspect of the present invention, a method for preparing the fluorescent dye of formula (I) is provided, comprising reacting a brominated aromatic ring compound of formula (II-1-1), (II-1-2), (II-1-3), or (II-1-4) with a ketone of (II-2) to obtain a fluorescent dye of formula (I):
[0084]
[0085] The third aspect of the present invention provides a fluorescence-activated biological material specific labeling method, comprising the following steps: after the above-mentioned fluorescent dye is contacted with the biological material (including but not limited to protein, RNA or DNA), the dye and the biological material are covalently or non-covalently bound, thereby specifically activating the fluorescence of the dye molecule, and realizing the specific fluorescent labeling of the biological material. Those skilled in the art can use correspondingly prepared instruments and equipment to track and monitor the target substance after dye labeling. According to needs, the instruments and equipment used include equipment and facilities that can test or display fluorescence, such as fluorescence spectrometers, fluorescence microscopes, confocal fluorescence microscopes, microplate readers, flow cytometers and other equipment.
[0086] Optionally, the reaction medium of the labeling reaction is selected from a pure analyte solution (pure protein, pure DNA and RNA, etc.), a cell lysate or an in situ medium where the analyte is located; optionally, the in situ medium is an intracellular medium, an intracellular organelle medium, a living tissue medium, blood or body fluid.
[0087] A fourth aspect of the present invention provides a probe kit, characterized in that it comprises the above-mentioned fluorescent dye.
[0088] Optionally, the probe kit further comprises a biocompatible medium; optionally, the biocompatible medium is selected from at least one of dimethyl sulfoxide, a buffer, and physiological saline; optionally, the buffer comprises a phosphate buffer.
[0089] A fifth aspect of the present invention provides a pharmaceutical preparation, characterized in that it comprises the above-mentioned fluorescent dye.
[0090] Optionally, the pharmaceutical preparation is a pharmaceutical composition prepared by mixing fluorescent dyes with other compounds and suitable for administration to animals or humans. The pharmaceutical composition also includes a physiologically acceptable carrier for animals or humans.
[0091] Alternatively, physiologically acceptable carriers include water, saline, and may also include pharmaceutical agents such as buffers, and other pharmaceutical agents such as compatible preservatives used in pharmaceutical dosage forms. Preferably the carrier is a liquid, more preferably an aqueous solution.
[0092] The sixth aspect of the present invention also provides the in vitro application of the above-mentioned fluorescent dye, and the in vitro application includes the use of the above-mentioned fluorescent dye in the preparation of pharmaceutical preparations for in vitro disease detection, including but not limited to labeling fluorescent dye molecules on antibodies to detect various diseases through antigen-antibody interaction; or using fluorescent dye molecules as targets for screening nucleic acid aptamers, and using the screened aptamers for fluorescent imaging of target nucleic acids and as probes for the detection of various disease markers.
[0093] The seventh aspect of the present invention further provides the in vivo application of the above-mentioned fluorescent dye, and the in vivo application includes the use of the above-mentioned fluorescent dye in the preparation of an optical imaging system for in vivo fluorescence imaging detection or treatment; optionally, the in vivo fluorescence imaging detection or treatment includes performing fluorescence-guided surgery or in vitro tissue staining on humans or animals through fluorescence imaging or fluorescence lifetime imaging.
[0094] Fluorescence imaging conducted in animal experiments, including but not limited to in vivo imaging, brain imaging, etc. Fluorescence imaging conducted on humans, including but not limited to fluorescence-guided surgery and in vitro tissue staining.
[0095] The above-mentioned in vivo applications should include a complete set of optical imaging systems that can support in vivo fluorescence imaging, including but not limited to in vivo imagers and various optical fibers, laparoscopy, endoscopes, etc. used in conjunction with human fluorescence imaging. BRIEF DESCRIPTION OF THE DRAWINGS
[0096] Figure 1 For molecular rotor 2 (1×10 -5 M) Fluorescence emission intensity diagram under different viscosity conditions;
[0097] Figure 2 For molecular rotor 2 (1×10 -5 M) Linear relationship between viscosity condition and fluorescence intensity;
[0098] Figure 3 For molecular rotor 9 (1×10 -5 M) Fluorescence emission intensity diagram under different viscosity conditions;
[0099] Figure 4 For molecular rotor 9 (1×10 -5 M) Linear relationship between viscosity condition and fluorescence intensity;
[0100] Figure 5 For molecular rotor 12 (1×10 -5 M) Fluorescence emission intensity diagram under different viscosity conditions;
[0101] Figure 6 For molecular rotor 12 (1×10 -5 M) Linear relationship between viscosity condition and fluorescence intensity;
[0102] Figure 7 For molecular rotor 19 (1×10 -5 M) Fluorescence emission intensity diagram under different viscosity conditions;
[0103] Figure 8 For molecular rotor 19 (1×10 -5 M) Linear relationship between viscosity condition and fluorescence intensity;
[0104] Fig. 9 For molecular rotor 40 (1×10 -5 M) Fluorescence emission intensity diagram under different viscosity conditions;
[0105] Fig.10 For molecular rotor 40 (1×10 -5 M) Linear relationship between viscosity condition and fluorescence intensity;
[0106] Fig.11 The photostability test of molecular rotors 6, 12, 20, 40, 42 and comparison molecules 1 and 2;
[0107] Fig.12 For molecular rotor 6 (1×10 -5 M) Fluorescence lifetime diagram under different viscosity conditions;
[0108] Fig.13 For molecular rotor 12 (1×10 -5 M) Fluorescence lifetime diagram under different viscosity conditions;
[0109] Fig.14 For molecular rotor 19 (1×10 -5 M) Fluorescence lifetime diagram under different viscosity conditions;
[0110] Fig.15 For molecular rotor 20 (1×10 -5 M) Fluorescence lifetime diagram under different viscosity conditions;
[0111] Fig.16 For molecular rotor 41 (1×10 -5 M) Fluorescence lifetime diagram under different viscosity conditions;
[0112] Fig.17 For comparison molecule 3 (1×10 -5 M) Fluorescence lifetime diagram under different viscosity conditions;
[0113] Fig.18 For comparison molecule 4 (1×10 -5 M) Fluorescence lifetime diagram under different viscosity conditions;
[0114] Fig.19 Molecular rotors 6, 12, 20, 40, 42 and comparison molecules 1 and 2 (1×10 -6 M) Fluorescence background comparison in PBS;
[0115] Fig. 20 Maps for the specific localization of subcellular organelles (lysosomes, mitochondria, cell membranes, and endoplasmic reticulum, etc.) for molecular rotors 34, 35, 39, and 40;
[0116] Fig.21This is a fluorescence imaging diagram of the target protein in living cells after the molecular rotors 22, 41 and 42 specifically bind to the protein tags Halo-Tag or SNAP-Tag.
[0117] Fig. 22 Fluorescence imaging of low-abundance RNA using molecular rotors 5, 6, 12, and 19 specifically bound to RNA aptamers.
[0118] Fig.23 Figure 2 shows molecular rotors 20, 36 and 43 used for in vivo tumor fluorescence imaging. DETAILED DESCRIPTION
[0119] The specific embodiments of the present invention are described in detail below. It should be understood that the specific embodiments described herein are only used to illustrate the present invention and are not used to limit the present invention.
[0120] Example 1
[0121]
[0122] Synthesis of compound 2: Compound 1 (2.0 g, 9.6 mmol) was dissolved in 80 mL of tert-butyl alcohol solution, 4-dimethylaminopyridine DMAP (1.2 g, 9.6 mmol) was added, and the reaction system was stirred at room temperature for 10 minutes, and then di-tert-butyl dicarbonate (6.3 g, 29 mmol) was added to the above system, and then the reaction system was stirred at room temperature for 2 hours. After the reaction was completed, the solvent was removed by vacuum filtration, and the residue was purified by column chromatography to obtain compound 2 (2.1 g, yield 85%). 1 H-NMR (400MHz, DMSO-d6): δ=7.99 (d, J=1.6Hz, 1H), 7.65 (d, J=1.6Hz, 1H), 1.51 (s, 9H).
[0123] Synthesis of compound 3: Synthesized according to Angew.Chem.Int.Ed.2018,57,15702-15706. 1 H-NMR (400MHz, CDCl3): δ = 8.40 (d, J = 3.7Hz, 1H), 8.37 (d, J = 3.7Hz, 1H), 7.04 (d, J = 2.9Hz, 1H), 6.98 (dd, J = 8.8Hz, 2 .2Hz,1H),6.84(dd,J=9.5H,2.9Hz,1H),6.78(d,J=2.9Hz,1H),3.10(s,6H),1.01(s,9H),0.46(s,6H),0.26(s,6H).
[0124] Synthesis of molecular rotor 1: In a 100 mL three-necked flask, compound 2 (0.2 g, 0.76 mmol) was dissolved in THF (50 mL), and the system was cooled to -78 ° C under nitrogen protection. After 20 minutes, 1.6 M n-butyl lithium (0.47 mL, 0.76 mmol) was added dropwise to the reaction system, and the mixed solution was kept at -78 ° C and stirred for 30 minutes. Then, compound 3 (31 mg, 0.0075 mmol) was dissolved in THF and added dropwise to the reaction system. After the addition was completed, the reaction system was gradually restored to room temperature and kept at room temperature and stirred for 2 hours. After the reaction was completed, 2 M HCl solution was added to quench the reaction. DCM extraction, the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The residue was purified by column chromatography to obtain the product (23 mg, yield 66%). 1 H-NMR (400MHz, CDCl3): δ = 7.9 (d, J = 7.4Hz, 1H), 7.34-7.36 (m, 2H), 7.12 (d, J = 7.6Hz, 1H), 7.09 (d, J = 7.6Hz, 1H ),6.78(d,J=9.3Hz,1H),6.58(d,J=2.4Hz,1H),6.33(d,J=2.9Hz,1H),3.09(s,6H),1.56(s,9H),0.48(s,6H).
[0125] Example 2
[0126]
[0127] Synthesis of compound 5: Compound 4 (2.0 g, 9.1 mmol) was dissolved in 50 mL of methanol solution, concentrated sulfuric acid (1.5 mL) was added dropwise, and stirred overnight under heating reflux. The next day, the solvent was distilled off under reduced pressure, the resulting solid was diluted with water (20 mL), and alkalized with saturated sodium carbonate solution, extracted with EA, the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The product (2.1 g, yield 82%) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CDCl3): δ = 7.54 (s, 1H), 3.87 (s, 3H), 2.57 (s, 3H).
[0128] Synthesis of compound 6: The compound 6 was synthesized according to Chem. Commun., 2011, 47, 4162-4164. 1H-NMR (400MHz, CDCl3): δ = 8.37 (d, J = 8.8Hz, 2H), 7.04 (d, J = 2.9Hz, 2H), 6.98 (dd, J = 2.2, 8.8Hz, 2H), 1.01 (s, 18H), 0.46 (s, 6H), 0.26 (s, 12H).
[0129] Synthesis of molecular rotor 2: In a 100 mL three-necked flask, compound 5 (0.2 g, 0.72 mmol) was dissolved in THF (50 mL), and the system was cooled to -78 ° C under nitrogen protection. After 20 minutes, 1.6 M n-butyl lithium (0.45 mL, 0.72 mmol) was added dropwise to the reaction system, and the mixed solution was kept at -78 ° C and stirred for 30 minutes. Then, compound 6 (36 mg, 0.0072 mmol) was dissolved in THF and added dropwise to the reaction system. After the addition was completed, the reaction system was gradually restored to room temperature and kept at room temperature and stirred for 2 hours. After the reaction was completed, 2 M HCl solution was added to quench the reaction. DCM extraction, the organic phases were combined, dried over anhydrous sodium sulfate, the solvent was removed under reduced pressure, and the product (23 mg, yield 72%) was obtained after column chromatography purification. 1 H-NMR (400MHz, CDCl3): δ=7.46-7.27(m,2H),7.12(d,J=7.6Hz,1H),7.09(d,J=7.6Hz,1H),6.85(d, J=9.3Hz,1H),6.78(d,J=2.4Hz,1H),6.63(d,J=2.9Hz,1H),3.96(s,3H),2.01(s,3H),0.48(s,6H).
[0130] Example 3
[0131]
[0132] Synthesis of compound 7: synthesized with reference to Org. Lett. 2009, 11, 14, 3144-3147. 1 H-NMR (400MHz, CDCl3): δ = 7.87 (d, J = 4.2Hz, 1H), 7.13-7.08 (m, 2H).
[0133] Synthesis of compound 8: Synthesized according to Angew.Chem.Int.Ed.2018,57,6910. 1 H-NMR (400MHz, CDCl3): δ = 7.86 (d, J = 4.2Hz, 1H), 7.14-7.06 (m, 2H).
[0134] Synthesis of compound 9: Add compound 8 (2g, 13mmol) and 50mL acetonitrile to a 100mL dry single-necked flask. After dissolving, add NBS (2.6g, 14.5mmol) and ammonium acetate (51mg, 0.66mmol) under nitrogen protection and stir at room temperature. After the reaction is completed, the resulting solution is removed by vacuum distillation, extracted with EA / H2O system, washed with saturated NaCl, dried with anhydrous Na2SO4, and the organic solvent is removed by vacuum distillation. The crude product is purified by column chromatography to obtain the product with a yield of 69%. 1 H-NMR (400MHz, CDCl3): δ=7.84 (d, J=4.8Hz, 1H), 6.99 (dd, J=4.8, 0.4Hz, 1H).
[0135] Synthesis of compound 10: synthesized according to J.Am.Chem.Soc.2019,141,18,7562-7571, with a yield of 39%. 1 H-NMR (400MHz, CDCl3): δ = 8.40 (d, J = 9.0Hz, 2H), 6.84 (d, J = 9.0, 2.8Hz, 2H), 6.79 (d, J = 2.8Hz, 2H), 3.09 (s, 12H), 0.49 (s, 6H).
[0136] Synthesis of molecular rotor 3: refer to the synthesis method of molecular rotor 1, with a yield of 39%. 1 H-NMR (400MHz, CD3OD): δ = 12.86 (s, 1H), 7.16 (s, 2H), 6.88 (t, J = 7.5Hz, 2H), 6.81 (t, J = 7.5 Hz, 1H), 6.47 (d, J = 7.5Hz, 2H), 6.08 (d, J = 9.5Hz, 1H), 3.66 (q, J = 6.5Hz, 12H), 0.66 (s, 6H).
[0137] Example 4
[0138]
[0139] Synthesis of compound 11: refer to the synthesis method of compound 9, with a yield of 56%. 1 H-NMR (400MHz, CDCl3): δ=7.89 (d, J=1.6Hz, 1H), 7.45 (d, J=1.6Hz, 1H).
[0140] Synthesis of compound 12: refer to the synthesis method of compound 2, with a yield of 76%. 1H-NMR (400MHz, CDCl3): δ=7.86 (d, J=1.6Hz, 1H), 7.43 (d, J=1.6Hz, 1H), 1.53 (s, 9H).
[0141] Synthesis of compound 13: synthesized according to Dalton Trans., 2019, 48, 5665-5673. 1 H-NMR (400MHz, CDCl3): δ = 8.56 (d, J = 9.1Hz, 2H), 6.78 (d, J = 2.5Hz, 2H), 6.74 (dd, J = 2.6, 9.1Hz, 2H), 3.05 (s, 12H).
[0142] Synthesis of compound 14: refer to the synthesis method of molecular rotor 1, with a yield of 65%. 1 H-NMR (400MHz, CDCl3): δ=7.98 (d, J=, 7.4Hz, 1H), 7.39 (m, 2H), 7.21 (d, J= 7.6Hz, 1H), 7.09 (d, J= 7.6H z,1H),6.88(d,J=9.3Hz,1H),6.82(d,J=2.4Hz,1H),6.63(d,J=2.9Hz,1H),3.09(s,12H),1.56(s,9H).
[0143] Synthesis of molecular rotor 4: Compound 14 (50 mg, 0.082 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, N-Boc-ethylenediamine (14 mg, 0.09 mmol), condensing agent PyBop (64 mg, 0.12 mmol), and 0.1 mL of triethylamine were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, extracted with DCM, and the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. After purification by column chromatography, the obtained solid was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure to obtain the product (40 mg, yield 82%). 1H-NMR (400MHz, DMSO-d6): δ = 7.98 (d, J = 7.4Hz, 1H), 7.39 (m, 2H), 7.21 (d, J = 7.6Hz, 1H), 7.09 (d, J = 7.6Hz, 1H), 6.88 (d, J=9.3Hz,1H),6.82(d,J=2.4Hz,1H),6.63(d,J=2.9Hz,1H),3.46(t,J=7.8Hz,2H),3.09(s,12H),2.46(t,J=7.7Hz,2H).
[0144] Example 5
[0145]
[0146] Synthesis of compound 15: refer to the synthesis method of compound 2, with a yield of 65%. 1 H-NMR (400MHz, DMSO-d6): δ=7.88(d,J=1.6Hz,1H),7.56(d,J=1.6Hz,1H),1.51(s,9H).
[0147] Synthesis of compound 16: synthesized according to J.Am.Chem.Soc.2019,141,18,7562-7571, with a yield of 29%. 1 H-NMR (400MHz, CDCl3): δ = 8.27 (dd, J = 7.9, 0.6Hz, 2H), 6.72-6.79 (m, 4H), 3.09 (s, 12H), 1.72 (s, 6H).
[0148] Synthesis of compound 17: refer to the synthesis method of molecular rotor 1, with a yield of 55%. 1 H-NMR (400MHz, CDCl3): δ = 7.68 (d, J = 6.9Hz, 1H), 7.29 (m, 2H), 7.10 (d, J = 7.5Hz, 1H), 7.02 (d, J = 6.6Hz, 1H), 6.78(d,J=8.3Hz,1H),6.68(d,J=2.5Hz,1H),6.43(d,J=2.6Hz,1H),3.09(s,12H),1.56(s,9H),1.38(s,6H).
[0149] Synthesis of molecular rotor 5: Compound 17 (40 mg, 0.087 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, and tert-butyl [2-(2-aminoethoxy)ethyl]carbamate (20 mg, 0.096 mmol), condensing agent PyBop (68 mg, 0.13 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, extracted with DCM, and the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. After purification by column chromatography, the obtained solid was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure to obtain the product (29 mg, yield 67%). 1 H-NMR (400MHz, CDCl3): δ=7.68(d,J=6.9Hz,1H),7.29(m,2H),7.10(d,J=7.5Hz,1H),7.02(d,J=6.6Hz,1H),6.78(d,J=8.3Hz ,1H),6.68(d,J=2.5Hz,1H),6.43(d,J=2.6Hz,1H),3.66(t,J=7.8Hz,4H),3.26(t,J=6.9Hz,4H),3.09(s,12H),1.38(s,6H).
[0150] Example 6
[0151]
[0152] Synthesis of compound 18: refer to the synthesis method of compound 9, with a yield of 92%. 1 H-NMR (400MHz, DMSO-D6): δ = 10.63 (s, 1H), 8.46 (s, 1H), 7.82 (s, 1H).
[0153] Synthesis of compound 19: refer to the synthesis method of compound 2, with a yield of 95%. 1 H-NMR (400MHz, DMSO-D6): δ = 8.44 (s, 1H), 7.84 (s, 1H), 1.42 (s, 9H).
[0154] Synthesis of compound 20: referring to the synthesis method of molecular rotor 1, the yield was 73%. 1H-NMR (400MHz, CDCl3): δ = 8.35 (dd, J = 7.9, 1.7Hz, 1H), 7.40 (d, J = 7.9Hz, 1H), 7.30 (d, J = 2.8H z, 2H), 6.93 (d, J = 9.4Hz, 2H), 6.74 (dd, J = 9.5Hz, 2H), 3.26 (s, 12H), 1.56 (s, 9H), 1.38 (s, 6H).
[0155] Synthesis of molecular rotor 6: refer to the synthesis method of molecular rotor 5, with a yield of 73%. 1 H-NMR (400MHz, CDCl3): δ = 8.35 (dd, J = 7.9, 1.7Hz, 1H), 7.40 (d, J = 7.9Hz, 1H), 7.30 (d, J = 2.8Hz, 2H), 6.93 (d, J =9.4Hz, 2H), 6.74 (dd, J = 9.5Hz, 2H), 3.75 (t, J = 9.6Hz, 4H), 3.36 (t, J = 9.4Hz, 4H), 3.00 (s, 12H), 1.32 (s, 6H).
[0156] Example 7
[0157]
[0158] Synthesis of compound 21: Tellurophene (1 g, 5.6 mmol) and 40 mL of acetonitrile were added to a 100 mL dry single-necked flask. After tellurophene was dissolved, NBS (1.1 g, 6.2 mmol) and ammonium acetate (43 mg, 0.56 mmol) were added under nitrogen protection and stirred at room temperature. After the reaction was completed, the obtained solution was removed by vacuum distillation, extracted with EA / H2O system, washed with saturated NaCl, dried with anhydrous Na2SO4, and the organic solvent was removed by vacuum distillation. The obtained crude product was purified by column chromatography to obtain the product (1.2 g, yield 80.6%). 1 H-NMR (400MHz, CDCl3): δ = 6.98 (s, J = 9.2Hz, 1H), 6.81 (dd, J = 8.6Hz, 1H), 6.74 (d, J = 8.4Hz, 1H).
[0159] Synthesis of compound 22: In an ice bath and dry environment, trifluoroacetic anhydride (30 mL, 0.21 mol) was slowly added to a sulfuric acid solution (9.81 g, 0.1 mol) and stirred for 3 hours to completely dissolve the sulfuric acid. After the solution turned light brown, compound 21 (25.9 g, 0.1 mol) was added dropwise to the above mixed solution. After stirring for 10 minutes, cold water was added to the system to precipitate solids. After removing the liquid by vacuum distillation, a crude product was obtained. The obtained product was purified by column chromatography to obtain the product (34.8 g, yield 98%). 1 H-NMR (400MHz, CDCl3): δ=7.03 (s, J=7.0Hz, 1H), 6.96 (dd, J=8.2Hz, 1H).
[0160] Synthesis of compound 23: The compound 23 was synthesized according to J. Org. Chem. 2003, 68, 3344-3347, with a yield of 23%. 1 H-NMR (400MHz, CDCl3): δ = 8.42 (d, J = 9.2Hz, 2H), 6.81 (dd, J = 2.4, 9.2Hz, 2H), 6.74 (d, J = 2.4Hz, 2H), 3.11 (s, 12H).
[0161] Synthesis of molecular rotor 7: refer to the synthesis method of molecular rotor 1, with a yield of 52%. 1 H-NMR (400MHz, CDCl3): δ = 8.67 (s, J = 8.5Hz, 1H), 8.56 (d, J = 9.1Hz, 2H), 7.60 (s, J=6.5Hz,1H),6.83(dd,J=2.6,9.2Hz,2H),6.76(d,J=2.4Hz,2H),3.07(s,12H).
[0162] Example 8
[0163]
[0164] Synthesis of compound 24: refer to the synthesis method of compound 9, with a yield of 65%. 1 H-NMR (400MHz, DMSO-d6): δ=12.97(s,1H),12.75(s,1H),7.82(s,1H).
[0165] Synthesis of compound 25: refer to the synthesis method of compound 2, with a yield of 76%. 1 H-NMR (400MHz, DMSO-d6): δ=12.86(s,1H),7.86(s,1H),1.51(s,9H).
[0166] Synthesis of compound 26: Synthesized according to Chem. Eur. J. 2017, 23, 12114-12119, with a yield of 72%. 1 H-NMR (400MHz, CDCl3): δ = 8.42 (d, J = 9.0Hz, 2H), 6.80 (dd, J = 9.1, 2.8Hz, 2H), 6.72 (d, J = 2.8Hz, 2H), 3.08 (s, 12H), 0.60 (s, 6H).
[0167] Synthesis of compound 27: refer to the synthesis method of molecular rotor 1, with a yield of 34%. 1 H-NMR (400MHz, CDCl3): δ=7.85 (dd, J=6.8, 1.9Hz, 1H), 7.54 (d, J=7.6, 2.2Hz, 1H), 7.06 (d, J=2. 8Hz, 2H), 6.73 (d, J = 9.4Hz, 2H), 6.64 (dd, J = 9.2Hz, 1H), 3.06 (s, 12H), 1.56 (s, 9H), 0.68 (s, 6H).
[0168] Synthesis of molecular rotor 8: Compound 27 (50 mg, 0.096 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, tert-butyl 2-(2-(2-aminoethoxy)ethoxy)ethylcarbamate (26 mg, 0.011 mmol), condensing agent PyBop (75 mg, 0.14 mmol), and 0.1 mL of triethylamine were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, extracted with DCM, and the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. After purification by column chromatography, the obtained solid was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure to obtain the product (40 mg, yield 70%). 1 H-NMR (400MHz, CDCl3): δ = 7.85 (dd, J = 6.8, 1.9Hz, 1H), 7.54 (d, J = 7.6, 2.2Hz, 1H), 7.06 (d, J = 2.8Hz, 2H), 6.73 (d, J = 9.4Hz, 2H), 6.64 (d d,J=9.2Hz,1H),3.75(t,J=9.6Hz,4H),3.66(t,J=9.4Hz,4H),3.35(t,J=8.7Hz,2H),3.26(t,J=9.4Hz,2H),3.06(s,12H),0.68(s,6H).
[0169] Example 9
[0170]
[0171] Synthesis of compound 28: Synthesized according to J.Am.Chem.Soc.2012,134,5029-5031 and J.Am.Chem.Soc.2019,141,7562-7571, with a yield of 22%. 1 H-NMR (400MHz, CDCl3): δ = 7.42 (d, J = 9.0Hz, 2H), 6.80 (dd, J = 9.1, 2.8Hz, 2H), 3.47 (t, J = 8.1Hz, 4H), 3.05 (t, J = 8.1Hz, 4H), 2.90 (s, 6H), 0.44 (s, 6H).
[0172] Synthesis of compound 29: referring to the synthesis method of molecular rotor 1, the yield was 82%. 1 H-NMR (400MHz, CDCl3): δ = 7.9 (d, J = 7.4Hz, 1H), 7.34-7.36 (m, 2H), 6.80 (dd, J = 9.1, 2.8Hz, 2H), 6 .06(s,2H),3.34(t,J=7.8Hz,4H),3.09(t,J=8.0Hz,4H),2.90(s,6H),1.56(s,9H),0.44(s,6H).
[0173] Synthesis of molecular rotor 9: Compound 29 (30 mg, 0.06 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure, and then the obtained solid was dissolved in anhydrous DCM, and NHS (10 mg, 0.09 mmol), EDC (17 mg, 0.09 mmol), and 0.1 mL of triethylamine were added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure, and the product (25 mg, yield 76%) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CDCl3): δ=7.9 (d, J=7.4Hz, 1H), 7.34-7.36 (m, 2H), 6.80 (dd, J=9.1, 2.8Hz, 2H), 6.06 ( s,2H),3.34(t,J=7.8Hz,4H),3.09(t,J=8.0Hz,4H),2.90(s,6H),2.56(t,J=7.8Hz,4H),0.44(s,6H).
[0174] Example 10
[0175]
[0176] Synthesis of compound 30: refer to the synthesis method of compound 9, with a yield of 72%. 1 H-NMR (400MHz, DMSO-D6): δ = 12.63 (s, 1H), 9.46 (s, 1H), 7.82 (d, J = 7.6, 2.3Hz, 1H), 6.95 (d, J = 8.6, 2.4Hz, 1H).
[0177] Synthesis of compound 31: refer to the synthesis method of compound 2, with a yield of 88%. 1 H-NMR (400MHz, DMSO-D6): δ = 9.44 (s, 1H), 7.79 (d, J = 7.6, 2.3Hz, 1H), 6.96 (d, J = 8.6, 2.4Hz, 1H), 1.42 (s, 9H).
[0178] Synthesis of compound 32: Synthesized according to Chem. Eur. J. 2020, 26, 7912-7917, with a yield of 61%. 1 H-NMR (400MHz, CDCl3): δ = 8.31 (dd, J = 8.9, 5.8Hz, 2H), 7.64-7.58 (m, 2H), 7.37-7.28 (m, 3H), 7 .00(dd,J=14.7,2.4Hz,2H),6.72(dd,J=9.2,2.4Hz,2H),3.43-3.32(m,8H),2.03-1.99(m,8H).
[0179] Synthesis of compound 33: refer to the synthesis method of molecular rotor 1, with a yield of 78%. 1 H-NMR (400MHz, CDCl3): δ = 8.40 (dd, J = 8.8, 5.8Hz, 2H), 7.87 (s, 1H), 7.61 (m, 2H), 7.39 (s, 1H), 7 .34(m,3H),7.02(dd,J=14.6,2.4Hz,2H),6.72(dd,J=9.2,2.4Hz,2H),3.40(m,8H),2.01(m,8H).
[0180] Synthesis of molecular rotor 10: Compound 33 (25 mg, 0.041 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, 9-amino-4,7-dioxanonanoic acid tert-butyl ester (11 mg, 0.045 mmol), condensation agent PyBop (32 mg, 0.062 mmol), and 0.1 mL of triethylamine were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, extracted with DCM, and the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. After purification by column chromatography, the obtained solid was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure to obtain the product (19.3 mg, yield 66%). 1 H-NMR (400MHz, CDCl3): δ = 8.35 (s, 1H), 8.25 (s, 1H), 8.02 (d, J = 7.6Hz, 1H), 7.34 (m, 3H), 7.08 (dd, J = 14.6, 2.4Hz, 2H), 6.76 (dd, J = 9.2, 2.4Hz, 2H), 7.22(d,J=7.3Hz,1H),7.16(s,2H),6.62(s,2H),3.83(t,J=8.1Hz,4H),3 .23(s,2H),2.93(t,J=8.1Hz,4H),2.10(s,2H),3.40(m,8H),2.01(m,8H).
[0181] Embodiment 11
[0182]
[0183] Synthesis of compound 34: refer to the synthesis method of compound 2, with a yield of 65%. 1 H-NMR (400MHz, DMSO-d6): δ = 7.82 (s, 1H), 1.51 (s, 9H).
[0184] Synthesis of compound 35: referring to the synthesis method of molecular rotor 1, the yield was 78%. 1 H-NMR (400MHz, CDCl3): δ = 8.25 (d, J = 8.4Hz, 1H), 7.68 (d, J = 8.4Hz, 1H), 7.61 (t, J = 7. 2Hz,1H),7.03(d,J=7.2Hz,2H),6.92(s,2H),1.63(s,9H),1.37(s,12H),0.45(s,6H).
[0185] Synthesis of molecular rotor 11: Compound 35 (257 mg, 0.54 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure, and then the obtained solid was dissolved in 100 mL of anhydrous DCM. A catalytic amount of DMF (3 drops) was added, and the reaction system was cooled to 0°C and stirred for 5 minutes. Then, thionyl chloride (77 mg, 6.5 mmol) was added dropwise and kept at 85°C for 5 hours. The obtained mixed solution was rotary evaporated to remove the solvent to obtain the product with a yield of 79%. 1 H-NMR (400MHz, CDCl3): δ = 8.36 (d, J = 8.4Hz, 1H), 7.78 (d, J = 8.4Hz, 1H), 7.72 (t ,J=7.2Hz,1H),7.14(d,J=7.2Hz,2H),6.88(s,2H),1.39(s,12H),0.44(s,6H).
[0186] Example 12
[0187]
[0188] Synthesis of compound 36: refer to the synthesis method of molecular rotor 1, with a yield of 55%. 1 H-NMR (400MHz, CDCl3): δ = 7.80 (d, J = 6.9Hz, 1H), 7.30 (m, 2H), 7.21 (d, J = 7.5Hz, 1H), 7.13 (d, J = 6.6Hz, 1H), 6.89(d,J=8.3Hz,1H),6.79(d,J=2.5Hz,1H),6.54(d,J=2.6Hz,1H),3.10(s,12H),1.67(s,9H),1.49(s,6H).
[0189] Synthesis of molecular rotor 12: Compound 36 (40 mg, 0.084 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, and mercapto-triethylene glycol-amino (19 mg, 0.093 mmol), condensing agent PyBop (66 mg, 0.13 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The product (32, yield 62%) was obtained after purification by column chromatography. 1H-NMR (400MHz, CDCl3): δ = 8.36 (s, 1H), 8.25 (d, J = 7.5Hz, 1H), 7.89 (d, J = 6.9H z,1H),7.30(s,1H),7.21(d,J=7.5Hz,1H),7.13(d,J=6.6Hz,1H),6.89(d,J=8 .3Hz,1H),6.79(d,J=2.5Hz,1H),6.54(d,J=2.6Hz,1H),3.83(t,J=8.1Hz,4H) ,3.23(s,2H),3.10(s,12H),2.93(t,J=8.1Hz,4H),2.10(s,2H),1.49(s,6H).
[0190] Example 13
[0191]
[0192] Synthesis of compound 37: 5-(Thiophen-2-yl)thiophene-2-carbonitrile (4.77 g, 30 mmol) was dissolved in 20 mL of DMF, NBS (5.34 g, 30 mmol) was added in batches and stirred overnight. After the reaction was completed, the reaction system was poured into cold water, the formed solid was collected by filtration, washed with clean water and dried to obtain compound 37 with a yield of 95%. 1 H-NMR (400MHz, DMSO-d6): δ = 7.88 (d, J = 3.9Hz, 1H), 7.41 (d, J = 3.9Hz, 1H), 7.34 (d, J = 3.9Hz, 1H), 7.26 (d, J = 3.9Hz, 1H).
[0193] Synthesis of compound 38: The compound 38 was synthesized according to Chem. Commun., 2016, 52, 12290-12293, with a yield of 35%. 1 H-NMR (400MHz, CDCl3): δ = 8.28 (tq, J = 6.8, 2.6, 2.0Hz, 2H), 7.23 (ddd, J = 15.2, 4.1, 2.6Hz, 2H), 6.91 ( ddd,J=9.1,4.1,2.6Hz,2H),3.90(ddd,J=9.9,5.6,2.8Hz,2H),3.21-3.09(m,12H),1.24-1.11(m,3H).
[0194] Synthesis of compound 39: referring to the synthesis method of molecular rotor 1, the yield was 49%. 1H-NMR (400MHz, DMSO-d6): δ = 7.65-7.37 (m, 5H), 7.18 (t, J = 7.8Hz, 1H), 7.04 (td, J = 10.3, 6.8Hz, 2H), 6.83(dd,J=9.7,2.8Hz,2H), 4.09(dp,J=9.6,7.2Hz,2H), 3.38(s,12H), 1.24(dt,J=18.1,7.0Hz,3H).
[0195] Synthesis of molecular rotor 13: Compound 39 (20 mg, 0.038 mmol) obtained above was dissolved in HCl (9 M, 2 mL) solution, and the reaction system was heated under reflux and stirred overnight. After the reaction was completed, the solvent was distilled off under reduced pressure, and the obtained solid was recrystallized to obtain the pure product (16 mg, yield 87%). 1 H-NMR (400MHz, DMSO-d6): δ=7.53-7.34(m,3H),7.24(d,J=14.7Hz,2H),7.12(d,J=7.3Hz,1H),6.90-6.70(m,4H),3.30(s,12H).
[0196] Embodiment 14
[0197]
[0198] Synthesis of compound 40: In a 100 mL three-necked flask, 2-pyrroleboric acid (0.93 g, 8.4 mmol), 4-bromophenyl isothiocyanate (1.5 g, 7 mmol), Na2CO3 (1.86 g, 17.5 mmol), and 50 mL of a mixed solvent (toluene: ethanol: water = 1:1:1). Then tetrakis(triphenylphosphine)palladium (0.4 g, 0.35 mmol) was added, and the reaction system was heated to 80°C under nitrogen protection and stirred at reflux for 6 hours. After the reaction was completed, the reaction system was cooled to room temperature, NH4Cl was used to quench the reaction, and EA was used for extraction. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product (1.23 g, yield 88%) was obtained by column chromatography purification. 1 H-NMR (400MHz, CDCl3): δ = 7.58-7.56 (m, 1H), 7.41-7.34 (m, 3H), 7.29-7.26 (m, 2H), 7.13 (t, J = 4.4Hz, 1H).
[0199] Synthesis of compound 41: refer to the synthesis method of compound 9, with a yield of 74%. 1H-NMR (400MHz, CDCl3): δ = 7.47-7.37 (m, 3H), 7.27 (d, J = 7.8Hz, 1H), 7.16 (s, 1H), 7.14 (d, J = 8.0Hz, 1H).
[0200] Synthesis of compound 42: The compound 42 was synthesized according to the reference Chem. Eur. J. 2015, 21, 16754-16758, with a yield of 38%. 1 H-NMR (400MHz, CDCl3): δ = 8.29 (d, J = 9.0Hz, 1H), 8.26 (d, J = 9.0Hz, 1H), 7.26 (d, J = 3.0Hz, 1H), 7.21 (d, J = 2. 7Hz, 1H), 6.90 (dd, J = 9.0, 2.4Hz, 2H), 3.51 (q, J = 7.2Hz, 8H), 1.88 (d, J = 13.4Hz, 3H), 1.25 (t, J = 7.2Hz, 12H).
[0201] Synthesis of molecular rotor 14: refer to the synthesis method of molecular rotor 1, with a yield of 20%. 1 H-NMR (400MHz, CDCl3): δ = 7.78-7.75 (m, 2H), 7.66-7.64 (m, 3H), 7.42-7.38 (m, 2H), 7.26 (d, J = 2.4Hz, 1H), 6. 99(d,J=2.4Hz,2H),6.87(d,J=2.4Hz,2H),3.88-3.78(m,8H),2.06(d,J=13.6Hz,3H),1.38(t,J=6.0Hz,12H).
[0202] Embodiment 15
[0203]
[0204] Synthesis of compound 43: refer to the synthesis method of compound 40, with a yield of 84%. 1 H-NMR (400MHz, DMSO-d6): δ = 12.25 (s, 1H), 7.71 (s, 1H), 7.58 (s, 1H), 7.34 (s, 1H), 6.51-6.49 (m, 1H).
[0205] Synthesis of compound 44: The compound 44 was synthesized according to ACS Appl. Mater. Interfaces 2016, 8, 22953-22962, with a yield of 38%. 1H-NMR (400MHz, DMSO-d6): δ = 8.00 (d, J = 9.0Hz, 2H), 7.09 (m, 4H), 3.14 (s, 12H).
[0206] Synthesis of compound 45: refer to the synthesis method of molecular rotor 1, with a yield of 20%. 1 H-NMR (400MHz, CDCl3): δ = 7.65 (m, 3H), 7.4 (d, J = 4.8Hz, 2H), 7.37 (t, J = 7.8Hz, 2H), 7.22 (t, J = 7.8Hz, 2H), 7.08 (s, 1H), 3.58 (s, 12H).
[0207] Synthesis of molecular rotor 15: Compound 45 (20 mg, 0.044 mmol) and 50 mL of acetonitrile were added to a 100 mL dry single-necked flask. After dissolution, NIS (11 mg, 0.049 mmol) and ammonium acetate (0.17 mg, 0.002 mmol) were added under nitrogen protection and stirred at room temperature. After the reaction was completed, the obtained solution was distilled off under reduced pressure, extracted with EA / H2O system, washed with saturated NaCl, dried with anhydrous Na2SO4, and distilled off under reduced pressure to remove the organic solvent. The obtained crude product was purified by column chromatography with a yield of 89%. 1 H-NMR (400MHz, CDCl3): δ = 7.59 (d, J = 2.4Hz, 2H), 7.28 (s, 1H), 7.14 (m, 3H), 7.05 (dd, J = 2.4, 7.8Hz, 2H), 6.07 (d, J = 12.6Hz, 1H), 3.55 (s, 12H).
[0208] Example 16
[0209]
[0210] Synthesis of compound 46: refer to the synthesis method of compound 40, with a yield of 85%. 1 H-NMR (400MHz, CDCl3): δ = 7.86 (s, 1H), 7.66 (d, J = 3.9Hz, 1H), 7.35 (d, J = 4.4Hz, 1H), 7.25 (d, J = 3.9Hz, 1H), 7.08 (t, J = 4.4Hz, 1H), 1.53 (s, 9H).
[0211] Synthesis of compound 47: refer to the synthesis method of compound 9, with a yield of 78%. 1H-NMR (400MHz, CDCl3): δ=7.66 (d, J=3.9Hz, 1H), 7.22 (d, J=3.8Hz, 1H), 7.19 (d, J=3.9Hz, 1H), 7.02 (d, J=3.8Hz, 1H), 1.54 (s, 9H).
[0212] Synthesis of compound 48: referring to the synthesis method of molecular rotor 1, the yield was 65%. 1 H-NMR (400MHz, CDCl3): δ = 7.90 (d, J = 2.9Hz, 2H), 7.55-7.38 (m, 5H), 7.14 (d, J = 7.3Hz, 1H), 6.91 (dd, J = 10.3, 2.9Hz, 2H), 3.23 (s, 12H), 1.60 (s, 9H).
[0213] Synthesis of molecular rotor 16: Compound 48 was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure. The solid was then dissolved in 2 mL of methanol, and an aqueous solution of hydrogen peroxide (30-35%) was slowly added dropwise in batches. The mixture was vigorously stirred at room temperature. When the color of the solution changed, the reaction mixture was immediately diluted with 3 mL of 0.1% TFA aqueous solution. The product was then purified by column chromatography with a yield of 20%. 1 H-NMR (400MHz, CDCl3): δ=8.14(d,J=2.9Hz,2H),7.55-7.37(m,3H),7.26(d,J =9.5Hz,2H),7.14(d,J=8.0Hz,1H),6.92(dd,J=9.5,2.9Hz,2H),3.44(s,12H).
[0214] Embodiment 17
[0215]
[0216] Synthesis of compound 49: refer to the synthesis method of compound 9, with a yield of 89%. 1 H-NMR (400MHz, DMSO-d6): δ = 13.01 (s, 1H), 8.64 (s, 1H), 8.01 (d, J = 5.6Hz, 1H), 7.98-7.92 (m, 1H), 7.55 (d, J = 5.6Hz, 1H).
[0217] Synthesis of compound 50: refer to the synthesis method of compound 2, with a yield of 92%. 1H-NMR (400MHz, DMSO-d6): δ = 8.62 (s, 1H), 8.01 (d, J = 5.6Hz, 1H), 7.95 (m, 1H), 7.52 (d, J = 5.6Hz, 1H), 1.54 (s, 9H).
[0218] Synthesis of compound 51: Synthesized according to Angew.Chem.Int.Ed.2017,56,4197-4200 and J.Am.Chem.Soc.2012,134,5029-5031, with a yield of 18%. 1 H-NMR (400MHz, CDCl3): δ = 7.41 (m, 2H), 7.22 (s, 2H), 3.60 (t, J = 5.1Hz, 4H), 3.33 (s, 6H), 2.48 (t, J = 5.9Hz, 4H), 1.91 (dt, J = 5.9, 5.1Hz, 4H).
[0219] Synthesis of compound 52: refer to the synthesis method of molecular rotor 1, with a yield of 65%. 1 H-NMR (400MHz, CD3OD): δ = 7.43-7.26 (m, 3H), 7.22 (d, J = 7.5Hz, 1H), 7.08 (d, J = 2.8Hz, 2H), 6.42 (d, J = 2.8Hz, 1H), 6.39 (d,J=2.8Hz,1H),3.64(t,J=5.2Hz,4H),3.35(s,6H),2.49(t,J=5.8Hz,4H),1.92(dt,J=5.9,5.1Hz,4H),1.54(s,9H).
[0220] Synthesis of molecular rotor 17: refer to the synthesis method of molecular rotor 4, with a yield of 56%. 1 H-NMR (400MHz, CD3OD): δ = 7.45-7.28 (m, 3H), 7.20 (d, J = 7.5Hz, 1H), 7.06 (d, J = 2.8Hz, 2H), 6.40 (d, J = 2.8Hz, 1H), 6.36 (d, J = 2.8Hz, 1H), 3.65 (t,J=5.2Hz,4H),3.46(t,J=7.8Hz,2H),3.35(s,6H),2.49(t,J=5.8Hz,4H),2.46(t,J=7.7Hz,2H),1.92(dt,J=5.9,5.1Hz,4H),1.54(s,9H).
[0221] Embodiment 18
[0222]
[0223] Synthesis of compound 54: synthesized according to Angew.Chem.Int.Ed.2017,56,4197-420, with a yield of 20%. 1 H-NMR (400MHz, CDCl3): δ = 8.26 (d, J = 9.0Hz, 2H), 7.21 (d, J = 2.7Hz, 2H), 6.90 (d, J = 2.4Hz, 2H), 3.51 (q, J = 7.2Hz, 8H), 1.25 (t, J = 7.2Hz, 12H).
[0224] Synthesis of molecular rotor 18: refer to the synthesis method of molecular rotor 1, with a yield of 72%. 1 H-NMR (400MHz, CDCl3): δ = 7.62 (d, J = 3.0Hz, 1H), 7.36 (d, J = 7.0Hz, 1H), 7.25 (s, 1H), 7.03 (d, J = 7.4Hz, 1H), 6.95 (s,1H),6.92(s,1H),6.46(d,J=2.9Hz,1H),6.43(d,J=3.0Hz,1H),3.48(q,J=7.2Hz,8H),1.26(t,J=7.2Hz,12H).
[0225] Embodiment 19
[0226]
[0227] Synthesis of compound 55: refer to the synthesis method of compound 2, with a yield of 87%. 1 H-NMR (400MHz, DMSO-d6): δ = 8.62 (s, 1H), 8.01 (d, J = 5.6Hz, 1H), 7.95 (m, 1H), 1.54 (s, 9H).
[0228] Synthesis of compound 56: The compound 56 was synthesized according to J. Am. Chem. Soc. 2012, 134, 5029-5031, with a yield of 17%. 1 H-NMR (400MHz, CDCl3): δ = 8.21 (s, 2H), 6.51 (s, 2H), 3.47 (t, J = 8.1Hz, 4H), 3.05 (t, J = 8.1Hz, 4H), 2.90 (s, 6H), 0.44 (s, 6H).
[0229] Synthesis of compound 57: referring to the synthesis method of molecular rotor 1, the yield was 36%. 1H-NMR (400MHz, CD3OD): δ = 8.05 (s, 1H), 8.02 (d, J = 7.3Hz, 2H), 7.22 (d, J = 7.3Hz, 1H), 7.16 (s, 1H), 6.62 ( s,2H),3.83(t,J=8.1Hz,4H),3.23(s,6H),2.93(t,J=8.1Hz,4H),1.50(s,9H),0.58(s,3H),0.56(s,3H).
[0230] Synthesis of compound 58: Referring to the synthesis method of molecular rotor 8, the obtained molecule (0.2 g, 0.34 mmol) was dissolved in 50 mL DCM, and a catalytic amount of dimethylaminopyridine (DMAP) and maleic anhydride (33 mg, 0.34 mmol) were added, and the reaction system was stirred for 2 hours. After the reaction was completed, the DCM / NaHCO3 aqueous solution was extracted, and the aqueous phase was acidified to pH = 3 using dilute hydrochloric acid. The organic phases were combined, dried over anhydrous Na2SO4, and the organic solvent was removed by distillation under reduced pressure. The crude product was purified by column chromatography with a yield of 47%. 1 H-NMR (400MHz, CD3OD): δ = 9.78 (s, 1H), 8.05 (s, 1H), 8.02 (d, J = 7.3Hz, 2H), 7.22 (d, J = 7.3Hz, 1H), 7.16 (s, 1H), 6.62 (s, 2H), 6.44-6.26 (dd,J=13.1Hz,2H),3.83(t,J=8.1Hz,4H),3.68-3.55(m,10H),3.32(t,J=5.1Hz,2H),3.23(s,6H),2.93(t,J=8.1Hz,4H),0.57(s,6H).
[0231] Synthesis of molecular rotor 19: Compound 58 (0.18 g, 0.27 mmol) and sodium acetate (0.11 g, 1.3 mmol) were added to 10 mL of acetic anhydride, stirred at 120°C for 45 minutes, and then the solvent was removed by distillation under reduced pressure. The mixture was extracted with DCM, and the organic phases were combined and dried over anhydrous Na2SO4. The crude product was purified by column chromatography with a yield of 81%. 1H-NMR (400MHz, CD3OD): δ = 8.10 (s, 1H), 8.05 (d, J = 7.3Hz, 2H), 7.31 (d, J = 7.3Hz, 1H), 7.27 (s, 1H), 6.69 (s, 2H), 6.25 (dd, J = 13 .1Hz,2H),3.83(t,J=8.1Hz,4H),3.75-3.47(m,10H),3.32(t,J=5.1Hz,2H),3.23(s,6H),2.93(t,J=8.1Hz,4H),0.57(s,6H).
[0232] Embodiment 20
[0233]
[0234] Synthesis of compound 59: refer to the synthesis method of compound 9, with a yield of 92%. 1 H-NMR (400MHz, CDCl3): δ = 13.02 (s, 1H), 8.30-8.28 (m, 1H), 8.10 (dd, J = 8.4, 1.6Hz, 1H), 7.89 (d, J = 8.4Hz, 1H).
[0235] Synthesis of compound 60: refer to the synthesis method of compound 2, with a yield of 95%. 1 H-NMR (400MHz, CDCl3): δ = 8.23-8.16 (m, 2H), 7.79 (d, J = 1.8Hz, 1H), 1.89 (s, 9H).
[0236] Synthesis of compound 61: The compound 61 was synthesized according to J.Am.Chem.Soc.2012,134,5029-5031, with a yield of 37%. 1 H-NMR (400MHz, CD3OD): δ = 7.41 (s, 2H), 7.17 (s, 2H), 5.59 (s, 2H), 3.28 (s, 6H), 2.05 (s, 6H), 1.52 (s, 12H), 0.53 (s, 6H).
[0237] Synthesis of compound 62: refer to the synthesis method of molecular rotor 1, with a yield of 50%. 1 H-NMR (400MHz, CD3OD): δ = 7.52-7.37 (m, 2H), 7.14 (d, J = 7.3Hz, 1H), 6.75 (s, 2H), 5.51 (s, 2H) ,3.29(s,6H),2.05(s,3H),1.58(s,9H),1.53(s,6H),1.49(s,6H),0.61(s,3H),0.59(s,3H).
[0238] Synthesis of molecular rotor 20: Compound 62 (50 mg, 0.078 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, 2-methoxyethylamine (6.5 mg, 0.086 mmol), condensing agent PyBop (61 mg, 0.12 mmol), and 0.1 mL of triethylamine were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and DCM was extracted. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. After purification by column chromatography, the product (31 mg, yield 62%) was obtained. 1 H-NMR (400MHz, CD3OD): δ=7.38-7.23(m,2H),7.04(s,2H),7.00-6.96(m,1H),6.59(s,2H),3.72(t,J=8.3Hz,4H),3.67(t,J=8.3Hz, 2H),3.53(s,3H)3.13(s,6H),3.07(t,J=8.2Hz,2H),2.04(s,3H),1.59(s,9H),1.54(s,6H),1.38(s,6H),0.48(s,3H),0.45(s,3H).
[0239] Embodiment 21
[0240]
[0241] Synthesis of compound 64: The compound 64 was synthesized according to J.Am.Chem.Soc.2012,134,5029-5031, with a yield of 53%. 1 H-NMR (400MHz, CD3OD): δ = 7.15 (s, 2H), 6.75 (s, 2H), 3.18 (t, J = 5.9Hz, 4H), 2 .85(s,6H),2.56(t,J=6.6Hz,4H),1.90(dt,J=6.6,5.9Hz,4H),0.44(s,6H).
[0242] Synthesis of compound 65: refer to the synthesis method of molecular rotor 1, with a yield of 16%. 1H-NMR (400MHz, CD3OD): δ = 12.08 (s, 1H), 7.49 (s, 1H), 7.22 (s, 2H), 7.08 (d, J = 7.3Hz, 1H), 6.68 (s, 2H), 3.60 ( t,J=5.1Hz,4H),3.33(s,6H),2.48(t,J=5.9Hz,4H),1.91(dt,J=5.9,5.1Hz,4H),0.57(s,3H),0.55(s,3H).
[0243] Synthesis of compound 66: referring to the synthesis method of molecular rotor 11, the yield is 68%. 1 H-NMR (400MHz, CD3OD): δ = 12.05 (s, 1H), 7.50 (s, 1H), 7.31 (s, 2H), 7.10 (d, J = 7.3Hz, 1H), 6.72 (s, 2H), 3.59 ( t,J=5.1Hz,4H),3.29(s,6H),2.52(t,J=5.9Hz,4H),1.91(dt,J=5.9,5.1Hz,4H),0.56(s,3H),0.54(s,3H).
[0244] Synthesis of molecular rotor 21: Compound 66 (80 mg, 0.17 mmol) was dissolved in 20 mL of anhydrous THF and added dropwise to a pressure bottle containing potassium thiocyanate (25 mg, 0.25 mmol). The mixture was heated under reflux at 60°C for about 2 hours. After the reaction, the solvent was removed by rotary evaporation, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by vacuum distillation. The product (60 mg, yield 72%) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CD3OD): δ = 12.08 (s, 1H), 7.68 (s, 1H), 7.30 (s, 2H), 7.21 (d, J = 7.3Hz, 1H), 6.70 (s, 2H), 3.59 ( t,J=5.1Hz,4H),3.31(s,6H),2.49(t,J=5.9Hz,4H),1.89(dt,J=5.9,5.1Hz,4H),0.58(s,3H),0.54(s,3H).
[0245] Embodiment 22
[0246]
[0247] Synthesis of compound 67: The compound 67 was synthesized according to J.Am.Chem.Soc.2012,134,5029-5031, with a yield of 27%. 1H-NMR (400MHz, DMSO-D6): δ = 7.23 (d, J = 6.56Hz, 2H), 6.87 (s, 2H), 3.60 (m, 4H), 3.24 (m, 4H), 3.01 (m, 4H), 1.21 (t, J = 6.99Hz, 6H).
[0248] Synthesis of compound 68: referring to the synthesis method of molecular rotor 1, the yield was 36%. 1 H-NMR (400MHz, DMSO-D6): δ = 8.23 (d, J = 7.01Hz, 1H), 7.91 (t, J = 7.52Hz, 1H), 7.82 (t, J = 7.66Hz, 1H), 7.48 ( d,J=7.56Hz,1H),6.78(s,2H),3.66(m,4H),3.29(m,4H),3.06(m,4H),1.56(s,9H),1.24(t,J=7.05Hz,6H).
[0249] Synthesis of molecular rotor 22: Compound 68 (35 mg, 0.059 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, 3-chloropropylamine (6 mg, 0.065 mmol), condensing agent PyBop (46 mg, 0.089 mmol), and 0.1 mL of triethylamine were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and DCM was extracted. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The product (24 mg, yield 66%) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CD3OD): δ = 8.62 (s, 1H), 8.12 (s, 1H), 7.64 (m, 2H), 7.23 (d, J = 6.5Hz, 1H), 6.85 (s, 1H), 5.93 (s, 1H), 4. 60(m,4H),4.12(m,4H)3.82(m,4H),3.75(m,2H),3.24(t,J=6.6Hz,2H),3.04(t,J=6.5Hz,2H),1.21(t,J=6.99Hz,6H).
[0250] Embodiment 23
[0251]
[0252] Synthesis of compound 69: The compound 69 was synthesized according to J.Am.Chem.Soc.2014,136,254-264, with a yield of 83%. 1H-NMR (400MHz, CDCl3): δ = 8.05 (d, J = 8.5Hz, 2H), 7.58 (d, J = 8.5Hz, 2H), 7.17 (d, J = 3.9Hz, 1H), 7.08 (d, J = 3.9Hz, 1H), 3.94 (s, 3H).
[0253] Synthesis of molecular rotor 23: refer to the synthesis method of molecular rotor 2, with a yield of 62%. 1 H-NMR (400MHz, CDCl3): δ = 7.94 (dt, J = 7.8, 1.0 Hz, 1H), 7.80 (td, J = 7.8, 1.0 Hz, 1H), 7.67 (td, J = 7.8, 1.0 Hz, 2H), 7.38 (dt, J = 7. 8,1.0Hz,2H),7.23(d,J=2.4Hz,2H),6.83(d,J=8.8Hz,2H),6.76(dd,J=8.8,2.4Hz,2H),3.92(s,3H),0.64(s,3H),0.56(s,3H).
[0254] Embodiment 24
[0255]
[0256] Synthesis of compound 70: refer to the synthesis method of compound 2, with a yield of 85%. 1 H-NMR (400MHz, CDCl3): δ = 7.54 (s, 1H), 2.57 (s, 3H), 1.56 (s, 9H).
[0257] Synthesis of compound 71: refer to the synthesis method of compound 40, with a yield of 95%. 1 H-NMR (400MHz, CDCl3): δ = 7.94 (s, 1H), 7.21 (d, J = 3.5Hz, 1H), 6.56 (d, J = 3.4Hz, 1H), 3.91 (s, 3H), 1.74 (s, 9H).
[0258] Synthesis of compound 72: refer to the synthesis method of compound 9, with a yield of 89%. 1 H-NMR (400MHz, CDCl3): δ = 7.82 (s, 1H), 7.76 (dd, J = 8.3, 2.6Hz, 1H), 2.56 (s, 3H), 1.75 (s, 9H).
[0259] Synthesis of compound 73: The compound 73 was synthesized according to J.Am.Chem.Soc.2012,134,5029-5031, with a yield of 20%. 1H-NMR (400MHz, CD3OD): δ = 7.15 (s, 2H), 7.02 (s, 2H), 3.60 (t, J = 5.8Hz, 4H), 3.48 (t, J = 5.9Hz, 4H), 3.18 (t, J = 5.9Hz, 4H), 2.85 (s, 6H), 0.60 (s, 6H).
[0260] Synthesis of molecular rotor 24: Referring to the synthesis method of molecular rotor 1, the obtained compound was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by vacuum distillation, and the product was obtained after purification by column chromatography with a yield of 52%. 1 H-NMR (400MHz, CD3OD): δ=7.49-7.32(m,3H),7.22(s,1H),7.08(d,J=7.3Hz,1H),6.68(s,1H),3.68(t,J=5. 9Hz,4H),3.52(t,J=5.9Hz,4H),3.23(t,J=5.9Hz,4H),2.19(s,3H),1.12(s,6H),0.55(s,3H),0.57(s,3H).
[0261] Embodiment 25
[0262]
[0263] Synthesis of compound 74: refer to the synthesis method of compound 40, with a yield of 92%. 1 H-NMR (400MHz, CDCl3): δ = 7.68 (s, 1H), 7.49-7.32 (m, 4H), 7.01 (d, J = 8.3Hz, 1H), 6.82 (d, J = 8.3Hz, 1H).
[0264] Synthesis of compound 75: refer to the synthesis method of compound 9, with a yield of 85%. 1 H-NMR (400MHz, CDCl3): δ = 7.52-7.36 (m, 4H), 7.05 (d, J = 8.1Hz, 1H), 6.87 (d, J = 8.2Hz, 1H).
[0265] Synthesis of compound 76: synthesized according to Dyes and Pigments 99 (2013) 1132-1136, with a yield of 20%. 1 H-NMR (400MHz, CD3OD): δ = 6.92 (s, 2H), 6.78 (s, 2H), 3.57 (s, 8H), 3.4 (t, J = 5.9Hz, 8H), 1.12 (t, J = 6.9Hz, 12H), 0.66 (s, 6H).
[0266] Synthesis of compound 77: refer to the synthesis method of molecular rotor 1, with a yield of 16%. 1 H-NMR (400MHz, CD3OD): δ = 8.12 (s, 1H), 7.61-7.55 (m, 4H), 7.44 (m, 2H), 7.23 (d, J = 6.5Hz, 1H), 6 .87(s,2H),3.60(m,8H),3.24(m,6H),3.01(m,6H),1.21(t,J=6.8Hz,6H),0.86(t,J=6.7Hz,6H).
[0267] Synthesis of molecular rotor 25: Compound 77 (45 mg, 0.072 mmol) was dissolved in 20 mL DCM, TMS.Cl (16.5 mg, 0.15 mmol) and KNO3 (15.3 mg, 0.15 mmol) were added respectively, and then the reaction system was stirred at 30° C. After the reaction was completed, the mixed solution was cooled to room temperature, and then filtered to remove the filter residue, and the filtrate was extracted with water, the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. After purification by column chromatography, the product (45 mg, yield 90%) was obtained. 1 H-NMR (400MHz, CD3OD): δ = 8.23 (s, 1H), 7.60-7.52 (m, 4H), 7.45 (m, 2H), 7.19 (d, J = 6.6Hz, 1H), 6 .85(s,2H),3.62(m,8H),3.26(m,6H),3.20(m,6H),1.21(t,J=6.9Hz,6H),0.86(t,J=6.2Hz,6H).
[0268] Embodiment 26
[0269]
[0270] Synthesis of compound 80: referring to the synthesis method of molecular rotor 1, the yield was 29%. 1 H-NMR (400MHz, CD3OD): δ = 8.01 (d, J = 7.3Hz, 1H), 7.79-7.61 (m, 2H), 6.97 (d, J = 1.6Hz, 2H), 6.74-6.59 (m, 4 H), 4.32 (t, J = 7.3Hz, 4H), 3.44 (t, J = 5.3Hz, 4H), 2.42 (m, J = 6.9Hz, 8H), 2.36 (s, 6H), 0.73 (t, J = 5.5Hz, 6H).
[0271] Synthesis of molecular rotor 26: synthesized according to J.Am.Chem.Soc.2019,141,14491-14495, with a yield of 62%. 1 H-NMR (400MHz, CD3OD): δ = 8.00 (d, J = 7.6Hz, 1H), 7.79 (t, J = 7.4Hz, 1H), 7.72 (t, J = 7.5Hz, 1H), 7.19 (d, J = 7.6Hz, 1H ),6.87(s,2H),6.80(d,J=8.8Hz,2H),6.62(d,J=8.8Hz,1H),3.61(s,8H),3.53(s,8H),3.18(s,12H),0.73(s,6H).
[0272] Embodiment 27
[0273]
[0274] Synthesis of compound 82: Synthesized according to Chem. Commun., 2020, 56, 715-718, with a yield of 74%. 1 H-NMR (400MHz, CDCl3): δ = 8.26 (d, J = 7.8Hz, 2H), 6.95 (s, 2H), 6.91 (d, J = 7.8Hz, 2H), 3.80 (s, 8H), 2.76 (s, 8H), 1.69 (s, 6H).
[0275] Synthesis of compound 83: referring to the synthesis method of molecular rotor 1, the yield was 67%. 1 H-NMR (400MHz, CD3OD): δ = 7.30 (d, J = 1.8Hz, 1H), 7.27 (d, J = 7.8Hz, 2H), 7.05 (d, J = 9.0Hz, 2 H),6.89(dd,J=1.8,7.8Hz,2H),4.10(t,J=4.8Hz,8H),2.79(t,J=4.8Hz,8H),1.77(s,6H).
[0276] Synthesis of molecular rotor 27: Compound 83 (61.3 mg, 0.1 mmol) was dissolved in 20 mL of DCM and added dropwise at 0°C to 10 mL of DCM containing 3-chloroperoxybenzoic acid (138 mg, 0.81 mmol). The reaction system was stirred at 0°C for 2 hours, then cooled to room temperature and stirred for 4 hours. After the reaction was completed, the reaction solution was washed with NaHSO3 and HClO4 solutions in sequence. The organic phase was collected, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product (20 mg, yield 30%) was obtained after purification by column chromatography. 1H-NMR (400MHz, CD3OD): δ = 7.41 (d, J = 2.4Hz, 1H), 7.30 (d, J = 7.8Hz, 2H), 7.18 (d, J = 9.6Hz, 2 H),7.02-7.00(dd,J=2.4Hz,2H),4.23(t,J=4.8Hz,8H),3.23(t,J=4.8Hz,8H),1.81(s,6H).
[0277] Embodiment 28
[0278]
[0279] Synthesis of compound 84: refer to the synthesis method of compound 40, with a yield of 90%. 1 H-NMR (400MHz, DMSO-d6): δ = 11.94 (s, 1H), 7.90 (d, J = 7.6Hz, 1H), 7.09 (d, J = 7.4Hz, 1H), 6.48 (d, J = 9.6Hz, 2H).
[0280] Synthesis of compound 85: The compound 85 was synthesized according to the literature Res Chem Intermed (2013) 39: 4121-4125, with a yield of 96%. 1 H-NMR (400MHz, DMSO-d6): δ = 12.46 (s, 1H), 11.94 (s, 1H), 7.90 (d, J = 7.6Hz, 1H), 7.11 (d, J = 7.4Hz, 1H), 6.45 (d, J = 9.6Hz, 2H).
[0281] Synthesis of compound 86: refer to the synthesis method of compound 9, with a yield of 88%. 1 H-NMR (400MHz, DMSO-d6): δ = 12.25 (s, 1H), 11.83 (s, 1H), 7.01 (d, J = 7.4Hz, 1H), 6.51 (d, J = 9.4Hz, 2H).
[0282] Synthesis of molecular rotor 28: Refer to the synthesis method of molecular rotor 1, with a yield of 68%. 1 H-NMR (400MHz, CD3OD): δ = 12.02 (s, 1H), 11.71 (s, 1H), 7.85 (d, J = 7.4Hz, 2H), 7.54 (dd, J = 7.6, 2.2Hz, 2H),7.06(d,J=2.8Hz,2H),6.62(d,J=9.4Hz,2H),6.53(dd,J=9.2Hz,1H),3.06(s,12H),0.68(s,6H).
[0283] Embodiment 29
[0284]
[0285] Synthesis of compound 87: synthesized according to ACS Appl. Energy Mater. 2019, 2, 5600-5612, with a yield of 75%. 1 H-NMR (400MHz, CDCl3): δ = 7.32 (d, J = 4.8Hz, 2H), 7.20 (d, J = 4.8Hz, 2H), 0.55 (s, 6H).
[0286] Synthesis of compound 88: synthesized according to ACS Appl. Energy Mater. 2019, 2, 5600-5612, with a yield of 69%. 1 H-NMR (400MHz, CDCl3): δ = 9.88 (s, 1H), 7.74 (s, 1H), 7.42 (d, J = 4.8Hz, 1H), 7.15 (d, J = 4.8Hz, 1H), 0.47 (s, 6H).
[0287] Synthesis of compound 89: refer to the synthesis method of compound 9, with a yield of 93%. 1 H-NMR (400MHz, CDCl3): δ = 9.86 (s, 1H), 7.73 (s, 1H), 7.11 (s, 1H), 0.46 (s, 6H).
[0288] Synthesis of compound 90: Synthesized according to Nat Methods 17, 815-821 (2020), with a yield of 43%. 1 H-NMR (400MHz, CD3OD): δ=7.69-7.59(m,2H),7.33(d,J=9.2Hz,2H),7.21-7.16(m,2H),4.27-4.13(m,8H),3.94(m,4H),1.51(s,6H).
[0289] Synthesis of molecular rotor 29: Refer to the synthesis method of molecular rotor 1, with a yield of 76%. 1 H-NMR (400MHz, CD3OD): δ = 10.41 (d, J = 8.1Hz, 1H), 8.37 (dd, J = 8.2, 1.6Hz, 1H), 7.89 (d, J = 1.6Hz, 1H), 7.18 (d, J=9.2Hz,2H),6.70(dd,J=9.2,2.0Hz,2H),6.45(d,J=2.0Hz,2H),4.30-4.21(m,8H),4.08(m,4H),1.54(s,6H).
[0290] Embodiment 30
[0291]
[0292] Synthesis of compound 91: referring to the synthesis method of molecular rotor 1, the yield was 66%. 1 H-NMR (400MHz, CD3OD): δ = 7.75-7.67 (m, 2H), 7.53-7.46 (m, 5H), 7.39 (s, 1H), 6.78 (dd, J = 13.8, 2.6Hz, 2H), 6.7 7(d,J=8.8,5.9Hz,2H),6.45(dd,J=8.8,2.5Hz,2H),3.71(t,J=7.4Hz,8H),2.65(t,J=7.3Hz,8H),1.46(s,9H).
[0293] Synthesis of molecular rotor 30: Compound 91 (50 mg, 0.078 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, and sulfamethoxazole (16 mg, 0.085 mmol), condensing agent PyBop (61 mg, 0.12 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The product (48 mg, yield 82%) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CD3OD): δ=7.77(m,2H),7.71(m,5H),7.44(m,5H),7.24(m,2H),6.86(m,2 H), 6.20 (m, 1H), 5.89 (m, 1H), 4.35 (s, 2H), 3.75 (t, J = 7.4Hz, 8H), 2.56 (t, J = 7.4Hz, 8H).
[0294] Embodiment 31
[0295]
[0296] Synthesis of compound 92: refer to the synthesis method of compound 40, with a yield of 92%. 1 H-NMR (400MHz, CDCl3): δ=7.72-7.65(m,2H),7.47-7.41(m,1H),7.36-7.33(m,1H),6.84(m,1H),2.64(s,3H).
[0297] Synthesis of compound 93: refer to the synthesis method of compound 2, with a yield of 65%. 1 H-NMR (400MHz, CDCl3): δ = 7.69 (m, 2H), 7.44 (m, 1H), 7.40 (m, 1H), 6.84 (m, 1H), 2.64 (s, 3H), 1.76 (m, 9H).
[0298] Synthesis of compound 94: The compound 94 was synthesized according to J.Am.Chem.Soc.2015,137,4759-4765 with a yield of 74%. 1 H-NMR (400MHz, DMSO-d6): δ = 8.37 (d, J = 8.7Hz, 2H), 7.66-7.63 (m, 4H), 7.49 (s, 2H), 7.45 (dd, J = 2 .4,8.7Hz,2H),7.29(d,J=8.7Hz,2H),4.15(t,J=9.0Hz,4H),3.22(t,J=9.0Hz,4H),0.54(s,6H).
[0299] Synthesis of compound 95: referring to the synthesis method of molecular rotor 1, the yield was 76%. 1 H-NMR (400MHz, DMSO-d6): δ = 7.82 (d, J = 2.10Hz, 2H), 7.59-7.45 (m, 11H), 7.27 (d, J = 7.50Hz, 1H), 7.15 (d, J = 9. 10Hz,2H),4.41(t,J=7.50Hz,4H),3.25(t,J=7.50Hz,4H),2.05(s,3H),1.45(s,9H),0.70(s,3H),0.67(s,3H).
[0300] Synthesis of molecular rotor 31: Compound 95 (70 mg, 0.078 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, bromo-2,2'-oxybis(ethylamine) (9 mg, 0.087 mmol), condensing agent PyBop (61 mg, 0.12 mmol), and 0.1 mL of triethylamine were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and DCM was extracted. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The product (66 mg, yield 85%) was obtained after purification by column chromatography. 1H-NMR (400MHz, DMSO-d6): δ = 7.84-7.75 (m, 6H), 7.62 (d, J = 8.7Hz, 2H), 7.43-7.27 (m, 7H), 6.68 (m, 2H), 4. 43(t,J=6.6Hz,4H),4.13(t,J=6.1Hz,4H),3.87(t,J=5.6Hz,4H),3.33(m,4H),2.05(s,3H),0.70(s,6H).
[0301] Embodiment 32
[0302]
[0303] Synthesis of compound 96: Synthesized according to Nat Methods 17, 815-821 (2020), with a yield of 43%. 1 H-NMR (400MHz, CD3OD): δ = 7.27 (d, J = 9.2Hz, 2H), 6.78 (dd, J = 9.2, 2.0Hz, 2H), 6.61 (d, J = 2.0Hz, 2H), 5.55 ( dd,J=6.0,3.1Hz,2H),4.61-4.48(m,4H),4.39-4.23(m,4H),4.65-4.56(m,8H),4.15(s,2H),1.70(s,6H).
[0304] Synthesis of compound 97: referring to the synthesis method of molecular rotor 1, the yield was 69%. 1 H-NMR (400MHz, CD3OD): δ=8.19-8.13(m,1H),7.69(td,J=7.6,1.5Hz,1H),7.64(td,J=7.4,1.6Hz,1 H),7.49(d,J=9.2Hz,2H),7.23-7.18(m,1H),6.85(dd,J=9.2,2.0Hz,2H),1.55(s,9H),1.70(s,6H).
[0305] Synthesis of molecular rotor 32: Compound 97 (75 mg, 0.14 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, and diethylene glycol (16 mg, 0.15 mmol), DMAP (26 mg, 0.21 mmol), and EDC (40 mg, 0.21 mmol) were added. The mixture was stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The product (63 mg, yield 79%) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CD3OD): δ = 7.43 (d, J = 9.1Hz, 2H), 6.76 (dd, J = 9.2, 2.2Hz, 2H), 6.62 (d, J = 2.2Hz, 2H) ,5.59(dd,J=6.0,3.0Hz,2H),4.70-4.56(m,4H),4.47-4.34(m,4H),3.69-3.57(m,8H),1.70(s,6H).
[0306] Embodiment 33
[0307]
[0308] Synthesis of compound 98: refer to the synthesis method of compound 9, with a yield of 92%. 1 H-NMR (400MHz, CDCl3): δ = 8.29 (d, J = 8.7Hz, 1H), 7.61 (d, J = 1.9Hz, 1H), 7.43 (dd, J = 8.7, 1.9Hz, 1H), 7.16 (s, 1H), 2.57 (s, 3H).
[0309] Synthesis of compound 99: refer to the synthesis method of compound 2, with a yield of 95%. 1 H-NMR (400MHz, CDCl3): δ = 8.43 (d, J = 7.2Hz, 1H), 7.52-7.48 (m, 1H), 7.37 (t d,J=7.3,1.5Hz,1H),7.30(td,J=7.3,1.5Hz,1H),2.62(s,3H),1.62(s,9H).
[0310] Synthesis of compound 100: synthesized according to Nat Methods 17, 815-821 (2020), with a yield of 23%. 1H-NMR (400MHz, CD3OD): δ = 7.40 (d, J = 9.3Hz, 2H), 6.83 (d, J = 2.3Hz, 2H), 6.68 (dd, J = 9.4, 2.3Hz, 2H), 4.35-4.22 (m, 8H).
[0311] Synthesis of compound 101: refer to the synthesis method of molecular rotor 1, with a yield of 73%. 1 H-NMR (400MHz, CD3OD): δ=7.37 (dd, J=9.1, 0.5Hz, 2H), 6.72 (dd, J=9.2, 2.2Hz, 2H), 6.58 (d, J=2.2H z,3H),6.26(dd,J=6.0,3.0Hz,2H),4.66-4.53(m,4H),4.44-4.30(m,4H),2.37(s,3H),1.62(s,9H).
[0312] Synthesis of molecular rotor 33: Compound 101 (60 mg, 0.098 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, ethylene glycol (6.8 mg, 0.11 mmol), DMAP (18 mg, 0.15 mmol), and EDC (28 mg, 0.15 mmol) were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was removed by distillation under reduced pressure, and DCM was extracted. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product (48 mg, yield 82%) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CD3OD): δ=6.75 (d, J=8.6Hz, 2H), 6.26 (d, J=2.3Hz, 3H), 6.22 (dd, J=8.6, 2.3Hz, 2H), 6.05 (dd, J= 6.1,3.5Hz,2H),4.31-4.19(m,4H),4.12-4.00(m,4H),3.84(t,J=8.3Hz,2H),3.72(t,J=8.1Hz,2H),2.37(s,3H).
[0313] Embodiment 34
[0314]
[0315] Synthesis of compound 102: synthesized according to Org. Lett. 2009, 11, 14, 3144-3147. 1H-NMR (400MHz, CDCl3): δ=7.57 (d, J=2.1Hz, 1H), 7.13 (d, J=0.5Hz, 1H), 6.66 (dd, J=2.1, 0.5Hz, 1H).
[0316] Synthesis of compound 103: Synthesized according to Angew.Chem.Int.Ed.2018,57,6910. 1 H-NMR (400MHz, CDCl3): δ = 7.19 (d, J = 5.3Hz, 1H), 7.03 (dd, J = 5.3, 0.5Hz, 1H), 6.69 (d, J = 0.5Hz, 1H).
[0317] Synthesis of compound 104: refer to the synthesis method of compound 9, with a yield of 60%. 1 H-NMR (400MHz, CDCl3): δ=7.12 (d, J=5.1Hz, 1H), 6.96 (dd, J=5.1, 0.4Hz, 1H).
[0318] Synthesis of compound 105: refer to the synthesis method of compound 2, with a yield of 56%. 1 H-NMR (400MHz, CDCl3): δ = 7.16 (d, J = 5.3Hz, 1H), 6.91 (dd, J = 5.2, 0.4Hz, 1H), 1.42 (s, 9H).
[0319] Synthesis of compound 106: refer to the synthesis method of molecular rotor 1, with a yield of 65%. 1 H-NMR (400MHz, CD3OD): δ = 7.68 (d, J = 6.9Hz, 1H), 7.29 (m, 2H), 7.10 (d, J = 7.5Hz, 1H), 7.02 (d, J = 6.6Hz, 1H), 6.78(d,J=8.3Hz,1H),6.68(d,J=2.5Hz,1H),6.43(d,J=2.6Hz,1H),3.09(s,12H),1.56(s,9H),1.38(s,6H).
[0320] Synthesis of molecular rotor 34: Compound 106 (85 mg, 0.17 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, and N-(2-aminoethyl)morpholine (24 mg, 0.19 mmol), condensing agent PyBop (131 mg, 0.25 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The product (85 mg, yield 39%) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CD3OD): δ = 7.16-7.10 (m, 3H), 6.88 (t, J = 7.5Hz, 1H), 6.81 (t, J = 7.5Hz, 1H), 6.47 (d, J = 7.5Hz, 2H), 6.08 (d, J = 9. 5Hz,1H),3.70(q,J=7.2Hz,8H),3.52(t,J=7.0Hz,2H),3.36(t,J=5.6Hz,2H),1.54(t,J=7.2Hz,12H),0.62(s,3H),0.61(s,3H).
[0321] Embodiment 35
[0322]
[0323] Synthesis of compound 107: synthesized according to Angew. Chem. Int. Ed., 2017, 56, 4197-4200, with a yield of 12%. 1 H-NMR (400MHz, CD3OD): δ=7.39 (d, J=2.5Hz, 2H), 6.74 (d, J=8.7Hz, 2H), 6.40 (dd, J=8. 7,2.5Hz,2H),4.01(d,J=7.4Hz,2H),3.42(m,4H),2.36(s,6H),1.46(t,J=7.3Hz,6H).
[0324] Synthesis of compound 108: referring to the synthesis method of molecular rotor 1, the yield was 66%. 1H-NMR (400MHz, CD3OD): δ = 8.77 (t, J = 5.2Hz, 1H), 8.39 (d, J = 8.3Hz, 1H), 8.19 (dd, J = 8.2, 1.8Hz, 1H), 7.75 (d, J = 1.8Hz, 1H), 7.19 ( d,J=9.2Hz,2H),6.69(dd,J=9.3,2.0Hz,2H),4.47(d,J=2.0Hz,2H),3.54(m,4H),2.36(s,6H),1.76(s,9H),1.56(t,J=7.3Hz,6H).
[0325] Synthesis of molecular rotor 35: Compound 108 (75 mg, 0.15 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, (2-aminoethyl) triphenylphosphine bromide (65 mg, 0.17 mmol), condensing agent PyBop (120 mg, 0.23 mmol), and 0.1 mL of triethylamine were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and DCM was extracted. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The product (96 mg, yield 87%) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CD3OD): δ = 7.44 (t, J = 5.2Hz, 1H), 7.36 (m, 16H), 7.06 (d, J = 8.3Hz, 1H), 6.74 (dd, J = 8.2, 1.8Hz, 1H), 6.09 (d, J = 1.8Hz, 1H), 6.5 0(d,J=9.2Hz,2H),6.20(dd,J=9.3,2.0Hz,1H),4.07(d,J=2.0Hz,2H),3.45(m,4H),3.03(t,J=6.2Hz,2H),2.36(s,6H),1.56(t,J=7.3Hz,6H).
[0326] Embodiment 36
[0327]
[0328] Synthesis of compound 109: refer to the synthesis method of compound 40, with a yield of 76%. 1 H-NMR (400MHz, CDCl3): δ = 7.49 (s, 1H), 7.02 (d, J = 1.5Hz, 1H), 6.24 (m, 2H).
[0329] Synthesis of compound 110: refer to the synthesis method of compound 2, with a yield of 82%. 1H-NMR (400MHz, CDCl3): δ = 7.64 (dd, J = 8.2Hz, 1H), 6.94 (dt, J = 8.0, 1.6Hz, 1H), 6.85 (dt, J = 7.1Hz, 1H), 6.78 (m, 1H), 1.64 (s, 9H).
[0330] Synthesis of compound 111: synthesized according to Chem.Sci., 2019, 10, 9028-9037, with a yield of 20%. 1 H-NMR (400MHz, CDCl3): δ = 8.07 (s, 2H), 3.29-3.27 (m, 8H), 2.91-2.80 (m, 8H), 2.03-1.96 (m, 8H), 0.59 (s, 6H).
[0331] Synthesis of compound 112: referring to the synthesis method of molecular rotor 1, the yield was 66%. 1 H-NMR (400MHz, CDCl3): δ = 7.81 (d, J = 8.0Hz, 2H), 7.38 (d, J = 8Hz, 2H), 6.93 (s, 2H), 4.72 (s, 2H), 3.77-3.75 (m,4H),3.64(m,4H),3.39(s,4H),2.95-2.90(m,4H),2.75(m,4H),1.34(s,9H),0.68(s,3H),0.61(s,3H).
[0332] Synthesis of molecular rotor 36: obtained by referring to the literature Nat Commun 12, 4065 (2021), with a yield of 70%. 1 H-NMR (400MHz, CDCl3): δ = 7.76 (t, J = 5.3Hz, 1H), 7.43 (d, J = 8.2Hz, 1H), 7.22 (dd, J = 8.2, 1.8Hz, 1H), 6.79 (d, J = 1.8Hz, 1H), 6.36 ( d,J=9.2Hz,2H),3.35-3.30(m,8H),3.18-3.12(m,2H),2.85-2.82(m,8H),2.15-2.08(m,8H),1.55(d,J=0.7Hz,6H),0.56(s,6H).
[0333] Embodiment 37
[0334]
[0335] Synthesis of compound 114: refer to the synthesis method of molecular rotor 1, with a yield of 14%. 1H-NMR (400MHz, CD3OD): δ=7.65-7.37(m,2H),7.18(t,J=7.8Hz,1H),7.04(td,J=10.3,6.8Hz,3H),6.83(dd,J=9 .7,2.8Hz,2H),4.09(dp,J=9.6,7.2Hz,2H),3.38(s,12H),2.06(d,J=21.9Hz,3H),1.24(dt,J=18.1,7.0Hz,3H).
[0336] Synthesis of molecular rotor 37: refer to the synthesis method of molecular rotor 13, with a yield of 14%. 1 H-NMR (400MHz, CD3OD): δ=7.46-7.29(m,3H),7.08(d,J=7.5Hz,1H),6.43(d,J=6.1Hz,3H),3.12(s,12H),2.40(s,3H).
[0337] Embodiment 38
[0338]
[0339] Synthesis of compound 115: refer to the synthesis method of compound 9, with a yield of 90%. 1 H-NMR (400MHz, DMSO-d6): δ = 12.90 (s, 1H), 8.13 (d, J = 1.9Hz, 2H), 7.73 (s, 1H), 7.16 (s, 1H).
[0340] Synthesis of compound 116: refer to the synthesis method of compound 2, with a yield of 96%. 1 H-NMR (400MHz, DMSO-d6): δ = 8.15 (d, J = 1.9Hz, 2H), 7.65 (s, 1H), 7.21 (s, 1H), 1.65 (s, 9H).
[0341] Synthesis of compound 117: synthesized according to J. Med. Chem. 2009, 52, 10, 3328-3341, with a yield of 40%. 1 H-NMR (400MHz, CDCl3): δ = 7.75 (dd, J = 2.5, 9.0Hz, 2H), 6.54 (dd, J = 2.5, 8.5Hz, 2H), 6.49 (d, J = 2.5Hz, 2H), 5.65 (s, 4H).
[0342] Synthesis of compound 118: referring to the synthesis method of molecular rotor 1, the yield was 74%. 1H-NMR (400MHz, CDCl3): δ = 9.11 (s, 2H), 8.11 (d, J = 8.5Hz, 1H), 7.74 (m, 2H), 7.61 (m, 1H), 7.54 (m,1H),7.47(m,1H),7.38(d,J=9.9Hz,2H),7.24(d,J=8.5Hz,2H),5.47(s,2H),1.56(s,9H).
[0343] Synthesis of molecular rotor 38: Compound 118 (69 mg, 0.16 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was removed by distillation under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, ethylamine (8 mg, 0.17 mmol), condensation agent PyBop (122 mg, 0.23 mmol), and triethylamine 0.1 mL were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was removed by distillation under reduced pressure, DCM was extracted, the organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. After purification by column chromatography, the intermediate was obtained. The intermediate (50 mg, 0.12 mmol) and 1,3-propane sultone (30 mg, 0.24 mmol) were placed in a 50 mL round-bottom flask, and 20 mL of acetonitrile was added to the flask to dissolve. The reaction system was heated to 100 ° C in an oil bath under nitrogen protection and reacted for 20 hours. After the reaction is completed, the reaction system is cooled to room temperature, and the organic solvent in the system is removed by vacuum distillation. The residue is extracted with 100 mL of EA and water, and the organic phases are combined, dried over anhydrous sodium sulfate, and the solvent is removed by vacuum distillation. The product (13 mg, yield 20%) is obtained after purification by column chromatography. 1 H-NMR (400MHz, CD3OD): δ = 9.16 (s, 2H), 7.76 (d, J = 9.5Hz, 2H), 7.26 (d, J = 2.5Hz, 2H), 7.21 (d, J = 3.5Hz, 1H), 7. 07(d,J=3.5Hz,2H),6.95(dd,J=2.5,9.8Hz,2H),4.99(s,2H),4.02(s,2H),3.28(m,6H),1.81(t,J=2.5Hz,3H).
[0344] Embodiment 39
[0345]
[0346] Synthesis of compound 119: synthesized according to Dyes and Pigments 99 (2013) 1091-1100, with a yield of 39%. 1H-NMR (400MHz, CDCl3): δ = 9.83 (s, 1H), 7.61 (s, 1H), 7.07 (d, 1H), 1.47 (s, 6H).
[0347] Synthesis of compound 120: referring to the synthesis method of molecular rotor 1, the yield was 74%. 1 H-NMR (400MHz, CD3OD): δ = 9.84 (s, 1H), 7.43-7.26 (m, 3H), 7.22 (d, J = 7.5Hz, 1H ),7.08(d,J=2.8Hz,2H),7.02(s,1H),6.99(s,1H),3.20(s,12H),1.49(s,6H).
[0348] Synthesis of compound 121: synthesized according to J.Am.Chem.Soc.2021,143,912-924, with a yield of 97%. 1 H-NMR (400MHz, CDCl3): δ = 7.37 (s, 1H), 3.58-3.45 (m, 2H), 3.21-3.25 (m, 2H), 1.61-1.48 (m, 2H), 1.33-1.17 (m, 20H), 0.87 (t, J = 7.0Hz, 3H).
[0349] Synthesis of molecular rotor 39: First, compound 120 was oxidized to the aldehyde group according to the reference Catalysis Letters volume 151, pages 36-44 (2021) to obtain an intermediate, and then the intermediate (70 mg, 0.12 mmol) was dissolved in 10 mL of anhydrous DMF, HATU (50 mg, 0.13 mmol), HOBt (9 mg, 0.06 mmol), DIPEA (64 mg, 0.5 mmol) were added, and stirred under nitrogen protection. After stirring for 5 minutes, compound 121 (33 mg, 0.13 mmol) and DIPEA (32 mg, 0.25 mmol) were dissolved in 1 mL of anhydrous DCM and added to the above reaction system, and then the mixed system was stirred at room temperature under nitrogen protection for 24 hours. After the reaction was completed, the organic solvent in the system was removed by reduced pressure distillation, and then the crude product was purified by column chromatography to obtain the product (56 mg, yield 44%). 1H-NMR (400MHz, CDCl3): δ = 8.63 (d, J = 7.8Hz, 2H), 8.25 (d, J = 7.8Hz, 1H), 7.71 (td, J =7.5,1.0Hz,1H),7.63(td,J=7.5,1.0Hz,1H),7.56(d,J=9.0Hz,2H),6.82(s,1H),6 .69(dd,J=9.0,2.5Hz,2H),3.35-3.52(m,8H),2.31(t,J=7.3Hz,2H),2.18(t,J=7.7 Hz,2H),1.93-2.03(m,2H),1.47(s,6H),1.16-1.32(m,23H),0.87(t,J=6.9Hz,3H).
[0350] Embodiment 40
[0351]
[0352] Synthesis of compound 122: refer to the synthesis method of compound 40, with a yield of 92%. 1 H-NMR (400MHz, CDCl3): δ = 8.14 (s, 1H), 8.07 (s, 1H), 7.99 (m, 1H), 7.80 (d, J = 1.6Hz, 1H), 7.46 (m, 2H), 7.38 (m, 2H), 1.39 (s, 9H).
[0353] Synthesis of compound 123: refer to the synthesis method of compound 9, with a yield of 86%. 1 H-NMR (400MHz, CDCl3): δ = 8.12 (s, 1H), 7.84 (d, J = 8.4Hz, 1H), 7.79 (d, J = 1.6Hz, 1H), 7.62 (m, 2H), 7.48 (t, J = 7.2Hz, 2H), 1.37 (s, 9H).
[0354] Synthesis of compound 124: referring to the synthesis method of molecular rotor 1, the yield was 74%. 1 H-NMR (400MHz, CD3OD): δ = 8.12 (s, 2H), 7.75-7.70 (m, 4H), 7.60 (s, 1H), 7.16 (s, 1H), 6.78 (t, J = 7.2Hz, 2H), 6.44 (m, 3H), 3.02 (s, 12H), 1.37 (s, 9H), 0.65 (s, 6H).
[0355] Synthesis of compound 125: Synthesized according to J.Am.Chem.Soc.2021,143,912-924, with a yield of 97%. 1H-NMR (400MHz, CDCl3): δ = 7.43 (s, 1H), 7.02 (s, 1H), 3.78 (t, J = 5.3Hz, 2H), 3.71-3.58 (m, 44H), 3.15 (sxt, J = 5.4Hz, 2H).
[0356] Synthesis of molecular rotor 40: Compound 124 (93 mg, 0.15 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, compound 125 (102 mg, 0.17 mmol), condensing agent PyBop (117 mg, 0.23 mmol), and 0.1 mL of triethylamine were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and DCM was extracted. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. After purification by column chromatography, the product (162 mg, yield 61%) was obtained. 1 H-NMR (400MHz, CDCl3): δ = 8.62 (d, J = 7.5Hz, 1H), 8.25 (d, J = 7.5Hz, 1H), 7.70 (td, J = 7.53, 1.2Hz,2H),7.62(td,J=7.53,1.2Hz,1H),7.57(d,J=9.3Hz,1H),7.40-7.32(m,3H),6.70( dd,J=9.0,2.5Hz,1H),6.56(t,J=4.5Hz,1H),6.49(d,J=2.5Hz,1H),6.35(s,1H),3.69-3. 55(m,44H),3.50-3.39(m,8H),3.02(s,12H),2.30(t,J=7.0Hz,2H), 0.67(t,J=7.0Hz,6H).
[0357] Embodiment 41
[0358]
[0359] Synthesis of compound 126: The compound 126 was synthesized according to J. Am. Chem. Soc. 2000, 122, 1820-1821, with a yield of 64%. 1 H-NMR (400MHz, DMSO-d6): δ = 10.32 (s, 1H), 7.64 (d, J = 4.0Hz, 1H), 7.36-7.22 (m, 3H).
[0360] Synthesis of compound 127: refer to the synthesis method of compound 2, with a yield of 62%. 1H-NMR (400MHz, CDCl3): δ=7.87 (d, J=3.9Hz, 1H), 7.15 (d, J=3.9Hz, 1H), 7.12 (d, J=3.9Hz, 1H), 7.05 (d, J=4.0Hz, 1H), 1.45 (s, 9H).
[0361] Synthesis of compound 128: referring to the synthesis method of molecular rotor 1, the yield was 70%. 1 H-NMR (400MHz, CD3OD): δ = 7.68 (d, J = 3.9Hz, 2H), 7.31 (dd, J = 6.2, 3.3Hz, 2H), 7.04 (d, J = 8.9Hz, 2H), 6.83 (dd, J=8.9,2.8Hz,1H),6.77(dd,J=9.6,2.8Hz,2H),6.40(d,J=2.8Hz,1H),3.33(s,12H),0.60(s,3H),0.56(s,3H).
[0362] Synthesis of molecular rotor 41: Compound 128 (40 mg, 0.08 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, 6-[[4-(aminomethyl)phenyl]methoxy]-7H-purin-2-amine (24 mg, 0.089 mmol), condensing agent PyBop (63 mg, 0.12 mmol), and 0.1 mL of triethylamine were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and DCM was extracted. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. After purification by column chromatography, the product (38 mg, yield 68%) was obtained. 1 H-NMR (400MHz, CD3OD): δ = 8.33 (s, 1H), 8.25 (m, 3H), 7.95 (d, J = 7.1Hz, 1H), 7.56 (d, J = 8.0Hz, 2H), 7.46 (d, J = 8.0, 2H), 7.37 (d, J = 2.6Hz, 1H), 7.27(d,J=7.9Hz,1H),7.04(d,J=9.6Hz,2H),6.75(dd,J=9.6,2.6Hz,2H),5.66(s,2H),4.66(s,2H),3.35(s,12H),0.61(s,3H),0.60(s,3H).
[0363] Embodiment 42
[0364]
[0365] Synthesis of compound 129: referring to the synthesis method of molecular rotor 1, the yield was 56%. 1 H-NMR (400MHz, CD3OD): δ = 8.46 (s, 2H), 8.23 (d, J = 8.0Hz, 1H), 7.88 (t, J = 7.5Hz, 1H), 7.81 (t, J = 7.5Hz, 1H), 7.47 (d, J = 7 .5Hz,1H),7.08(d,J=9.5Hz,2H),7.01(d,J=9.5Hz,2H),3.64(q,J=6.5Hz,12H),1.51(s,9H),0.65(s,3H),0.63(s,3H).
[0366] Synthesis of molecular rotor 42: Compound 129 (40 mg, 0.08 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF. 2-(2-(6-chlorohexyloxy)ethoxy)ethylamine (23 mg, 0.089 mmol), condensing agent PyBop (63 mg, 0.12 mmol), and 0.1 mL of triethylamine were added, and stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and DCM was extracted. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The product (18 mg, yield 34%) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CD3OD): δ = 8.22 (s, 1H), 7.92 (d, J = 7.8Hz, 2H), 7.37 (d, J = 2.6 Hz,2H),7.26(d,J=7.8Hz,2H),7.05(d,J=9.6Hz,2H),6.76(dd,J=9.6,2.6Hz, 2H),4.37(s,2H),3.71-3.61(m,8H),3.53-3.49(m,4H),3.35(s,12H),1.77- 1.70(m,2H),1.63-1.56(m,2H),1.48-1.37(m,2H),0.62(s,3H),0.61(s,3H).
[0367] Embodiment 43
[0368]
[0369] Synthesis of compound 130: synthesized according to Science 370, 424 (2020), with a yield of 80%. 1 H-NMR (400MHz, DMSO-d6): δ = 8.46-8.30 (s, 2H), 7.85-7.82 (m, 2H), 4.62 (m, 4H).
[0370] Synthesis of compound 131: refer to the synthesis method of compound 40, with a yield of 92%. 1 H-NMR (400MHz, DMSO-d6): δ = 8.38 (s, 1H), 8.25 (s, J = 15.0Hz, 1H), 8.00-7.91 (m, 2H), 7.73-7.69 (m, 1H), 3.72 (s, 2H).
[0371] Synthesis of molecular rotor 43: refer to the synthesis method of molecular rotor 1, with a yield of 70%. 1 H-NMR (400MHz, CD3OD): δ = 7.40 (m, 4H), 7.22 (s, 2H), 7.08 (d, J = 7.3Hz, 1H), 6.68 (s, 2H), 4.8 (s, 2H), 3.60 ( t,J=5.1Hz,4H),3.33(s,6H),2.48(t,J=5.9Hz,4H),1.91(dt,J=5.9,5.1Hz,4H),0.57(s,3H),0.55(s,3H).
[0372] Embodiment 44
[0373]
[0374] Synthesis of compound 132: refer to the synthesis method of molecular rotor 1, with a yield of 56%. 1 H-NMR (400MHz, CD3OD): δ = 8.38 (s, 1H), 8.27 (d, J = 7.8Hz, 1H), 7.30 (d, J = 8.0Hz, 1H), 6.73 (d, J = 12 .3Hz,4H),6.57(d,J=8.7Hz,1H),3.23(s,8H),2.47(s,8H),2.24(s,6H),1.42(s,9H),0.66(s,6H).
[0375] Synthesis of molecular rotor 44: refer to the synthesis method of molecular rotor 20, with a yield of 86%. 1 H-NMR (400MHz, CD3OD): δ = 8.41 (s, 1H), 8.30 (d, J = 8.0Hz, 1H), 7.23 (d, J = 8.0Hz, 1H), 6.89 (s, 2H), 6.82 (d, J = 9.0Hz, 2H), 6.69 ( d,J=8.8Hz,2H),3.72(t,J=8.3Hz,2H),3.67(t,J=8.3Hz,2H),3.63(s,8H),3.54(s,8H),3.20(s,6H),3.04(s,3H),0.66(s,6H).
[0376] Embodiment 45
[0377]
[0378] Synthesis of compound 133: Synthesized according to Chemistry of Materials (2007), 19(16), 4007-4015, with a yield of 50%. 1 H-NMR (400MHz, CDCl3): δ = 7.37 (d, J = 5.1Hz, 1H), 7.22 (s, 1H).
[0379] Synthesis of compound 134: Referring to Catalysis Letters volume 151, pages 36-44 (2021), the aldehyde group was oxidized to obtain the product with a yield of 83%. 1 H-NMR (400MHz, CDCl3): δ = 7.35 (d, J = 5.3Hz, 1H), 7.24 (s, 1H).
[0380] Synthesis of compound 135: refer to the synthesis method of compound 2, with a yield of 83%. 1 H-NMR (400MHz, CDCl3): δ = 7.35 (d, J = 5.3Hz, 1H), 7.24 (s, 1H), 1.51 (s, 9H).
[0381] Synthesis of compound 136: refer to the synthesis method of molecular rotor 1, with a yield of 56%. 1 H-NMR (400MHz, CD3OD): δ = 8.38 (s, 1H), 8.27 (d, J = 7.8Hz, 1H), 7.30 (d, J = 8.0Hz, 1H), 6.73 (d ,J=12.3Hz,4H),6.57(d,J=8.7Hz,1H),3.23(s,8H),2.47(s,8H),2.24(s,6H),1.51(s,9H).
[0382] Synthesis of compound 137: synthesized according to J.Am.Chem.Soc.2011,133,15280-15283, with a yield of 80%. 1 H-NMR (400MHz, CDCl3): δ=3.84-3.81(t,2H), 3.87-3.78(t,2H), 3.69-3.68(d,4H), 3.50-3.48(t,2H), 3.27(s,2H).
[0383] Synthesis of compound 138: After dissolving compound 136 (95 mg, 0.14 mmol) in 8 mL of anhydrous DCM, 2 mL of trifluoroacetic acid was added, and the mixture was stirred at room temperature for 2 hours. The solvent was removed by distillation under reduced pressure, and the resulting solid was dissolved in anhydrous DMF. Compound 140 (33 mg, 0.16 mmol), condensing agent PyBop (111 mg, 0.21 mmol), and 0.1 mL of triethylamine were added, and the mixture was stirred at room temperature for 1 hour. After the reaction was completed, the solvent was removed by distillation under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was removed by distillation under reduced pressure. The product (82 mg, yield 72%) was obtained after purification by column chromatography. 1 H-NMR (400MHz, CD3OD): δ = 8.17 (d, 1H), 7.79 (d, 1H), 7.16 (d, 1H), 6.69 (m, 4H), 6.56 (m, 2H), 3.83,(s,2H),3.73(t,2H),3.69(m,6H),3.37(m,2H),3.23(s,8H),2.47(s,8H),2.24(s,6H).
[0384] Synthesis of molecular rotor 45: refer to the synthesis method of molecular rotor 26, with a yield of 83%. 1 H-NMR (400MHz, CD3OD): δ = 8.41 (s, 1H), 8.30 (d, J = 8.0Hz, 1H), 7.23 (d, J = 8.0Hz, 1H), 6.89 (s, 2H), 6.82 (d, J = 9. 0Hz,2H),6.69(d,J=8.8Hz,2H),3.73(t,2H),3.69(m,6H),3.63(s,8H),3.54(s,8H),3.37(m,2H),3.20(s,12H).
[0385] Embodiment 46
[0386]
[0387] Synthesis of compound 139: refer to the synthesis method of compound 40, with a yield of 86%. 1 H-NMR (400MHz, CDCl3): δ = 7.35 (s, 1H), 7.25 (s, 1H), 7.12-7.01 (m, 2H).
[0388] Synthesis of compound 140: refer to the synthesis method of compound 2, with a yield of 66%. 1 H-NMR (400MHz, CDCl3): δ = 7.34 (s, 1H), 7.29 (s, 1H), 7.22-7.11 (m, 2H), 1.54 (s, 9H).
[0389] Synthesis of compound 141: Synthesized according to Angew.Chem.Int.Ed.2018,57,15702-15706 and Chem.Commun.,2016,52,12290-12293. 1 H-NMR (400MHz, CDCl3): δ = 8.40 (d, J = 3.7Hz, 1H), 8.37 (d, J = 3.7Hz, 1H), 7.04 (d, J = 2.9Hz, 1H), 6.98 (dd, J = 8.8Hz, 2. 2Hz, 1H), 6.84 (dd, J = 9.5H, 2.9Hz, 1H), 6.78 (d, J = 2.9Hz, 1H), 4.45 (s, 2H), 3.10 (s, 6H), 1.34 (q, J = 6.9, 6.1Hz, 3H).
[0390] Synthesis of compound 142: refer to the synthesis method of molecular rotor 1, with a yield of 66%. 1 H-NMR (400MHz, CD3OD): δ = 7.58-7.40 (m, 3H), 7.32 (d, J = 7.4Hz, 1H), 7.26-7.11 (m, 1H), 7.04-6.87 (m,3H),6.80(q,J=8.3Hz,2H),4.10(s,2H),3.21(s,6H),1.56(s,9H),1.34(q,J=6.9,6.1Hz,3H).
[0391] Synthesis of molecular rotor 46: Compound 142 (73 mg, 0.12 mmol) was dissolved in 8 mL of anhydrous DCM, and 2 mL of trifluoroacetic acid was added. After stirring at room temperature for 2 hours, the solvent was distilled off under reduced pressure, and then the obtained solid was dissolved in anhydrous DMF, and diglycolamine (14 mg, 0.13 mmol), condensing agent PyBop (92 mg, 0.18 mmol), and 0.1 mL of triethylamine were added. The mixture was stirred at room temperature for 1 hour. After the reaction was completed, the solvent was distilled off under reduced pressure, and the mixture was extracted with DCM. The organic phases were combined, dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The product (55 mg, yield 72%) was obtained after purification by column chromatography. 1H-NMR (400MHz, CD3OD): δ = 8.63 (dd, J = 8.2, 1.1Hz, 2H), 8.29 (dd, J = 7.8, 1.0Hz, 1H), 7.72 (td, J=8.0,1.8Hz,1H),7.65(td,J=7.8,1.0Hz,1H),7.58(d,J=9.3Hz,1H),7.07(t,J=4.5Hz,1H), 6.69(dd,J=9.3,2.8Hz,1H),6.49(d,J=2.8Hz,1H),6.36(s,1H),5.40(s,1H),4.51(t,J=9.1, 4.1,2.6Hz,2H),3.90(m,6H),3.32(d,J=3.7Hz,2H),3.10(s,6H),1.23(q,J=6.9,6.1Hz,3H).
[0392] Embodiment 47
[0393]
[0394] Synthesis of molecular rotor 47: refer to the synthesis method of molecular rotor 1, with a yield of 78%. 1 H-NMR (400MHz, CD3OD): δ = 7.47 (s, 1H), 7.31 (d, J = 8.0Hz, 1H), 7.16-7.12 (m, 2H), 7.03 (s, 1H) ),6.77(s,1H),6.20(s,1H),5.91(s,1H),3.64(q,J=6.5Hz,12H),0.65(s,3H),0.63(s,3H).
[0395] Embodiment 48
[0396]
[0397] Synthesis of compound 144: refer to the synthesis method of compound 40, with a yield of 86%. 1 H-NMR (400MHz, CDCl3): δ=8.07 (d, J=5.3Hz, 2H), 7.60 (t, J=7.6Hz, 3H), 7.10 (s, 1H), 6.54 (s, 1H).
[0398] Synthesis of molecular rotor 48: Refer to the synthesis method of molecular rotor 1, with a yield of 78%. 1H-NMR (400MHz, CD3OD): δ = 8.12 (d, J = 5.2Hz, 2H), 7.58 (t, J = 6.9Hz, 3H), 7.08 (m, 3H), 6.77 (d, J = 7.6Hz ,2H),6.20(d,J=6.5Hz,1H),5.90(t,J=7.8Hz,2H),3.64(q,J=6.5Hz,12H),0.65(s,3H),0.63(s,3H).
[0399] Comparative Example 1
[0400]
[0401] Synthesis of comparative molecule 1: synthesized according to the document Analyst, 2020, 145, 7736, with a yield of 12%. 1 H-NMR (400MHz, DMSO-d6): δ = 7.74 (d, J = 8.3Hz, 2H), 7.09 (d, J = 2.9Hz, 2H), 6.99 (d, J = 7. 8Hz, 2H), 6.64 (d, J = 9.3Hz, 2H), 6.40 (dd, J = 9.3, 2.9Hz, 2H), 2.96 (s, 12H), 0.15 (s, 6H).
[0402] Comparative Example 2
[0403]
[0404] Synthesis of comparative molecule 2: synthesized according to the reference J.Am.Chem.Soc.2019,141,7562-7571, with a yield of 47%. 1 H-NMR (400MHz, CD3OD): δ = 8.88 (d, J = 1.7Hz, 1H), 8.40 (dd, J = 7.9, 1.8Hz, 1H), 7.47 (d, J = 7.9Hz, 1H), 7.24 ( d,J=2.5Hz,2H),7.01(d,J=9.4Hz,2H),6.82(dd,J=9.4,2.6Hz,2H),3.34(s,3H),1.89(s,3H),1.77(s,3H).
[0405] Comparative Example 3
[0406]
[0407] Synthesis of comparative molecule 3: synthesized according to the document Nat Biotechnol 37, 1287-1293 (2019), with a yield of 90%. 1H-NMR (400MHz, DMSO-d6): δ = 8.45 (s, 1H), 7.92 (d, J = 8.6Hz, 2H), 7.85 (d, J = 8.3Hz, 3H), 7.73 (dd, J = 8.6, 3.9Hz, 1H), 7.21 ( d,J=1.9Hz,1H),7.11(d,J=1.9Hz,1H),6.96(dd,J=9.1,2.3Hz,1H),3.63-3.57(m,2H),3.52(t,J=5.7Hz,2H),3.05(s,3H).
[0408] Comparative Example 4
[0409]
[0410] Synthesis of comparative molecule 4: synthesized with reference to the literature Bioconjugate Chem. 2018, 29, 215-224, with a yield of 96%. 1 H NMR (400MHz, DMSO-d6): δ7.85(s,1H),7.48(s,2H),3.31(t,J=5.5Hz,4H),2.65(t,J=5.9Hz,4H),1.90–1.79(m,4H),1.5(s,9H).
[0411] Test Example 1
[0412] The fluorescent dyes (molecular rotors) prepared in Examples 1-48 were dissolved in dimethyl sulfoxide to prepare a concentration of 1×10 -2 M mother liquor, add each mother liquor into methanol and glycerol respectively, mix well, and prepare a final concentration of 1×10 -5 According to different fluorescent dyes, the maximum excitation wavelength of each fluorescent dye is used to detect its fluorescence emission spectrum under the same conditions. The results are shown in Table 1, indicating that the fluorescent dye of the present invention has long excitation and emission wavelengths, and the fluorescent dye in the near-infrared band can achieve red excitation and red emission, which is convenient for application in living fluorescent imaging. In addition, the fluorescent dye of the present invention has a very high fluorescence intensity ratio in glycerol and methanol, indicating that this type of fluorescent dye is sensitive to viscosity changes.
[0413] Table 1 Excitation and emission wavelengths of each molecular rotor in methanol and the ratio of fluorescence intensity in glycerol and methanol solutions
[0414]
[0415]
[0416]
[0417] Test Example 2
[0418] Molecular rotors 2, 9, 12, 19, and 40 were added to methanol and glycerol respectively to prepare a final concentration of 1×10 -5 The solution of M, according to the respective optimum excitation wavelength excitation, the fluorescence spectrum in glycerol and methanol is tested respectively, and the absorption value under the excitation wavelength is tested with a UV spectrometer, and the fluorescence quantum yield of each of them in methanol and glycerol is obtained by the calculation method of relative fluorescence quantum yield. In addition, the maximum absorption value of each of them in methanol is tested with a UV spectrometer, and the molar extinction coefficient of each of them is calculated by Lambert-Beer's law. Experimental data are summarized as Table 2, and the result shows that fluorescent dye of the present invention has a higher molar extinction coefficient, and the fluorescence quantum yield of (methanol) in the free state is lower, and has a higher fluorescence quantum yield under the environment of higher viscosity such as glycerol.
[0419] Table 2 Photophysical properties of representative molecules of molecular rotors in methanol and glycerol
[0420] name <![CDATA[E x / nm]]> <![CDATA[E m / nm]]> <![CDATA[ε(M -1 cm -1 )]]> QY(Methanol) QY(Glycerin) Molecular Rotor 2 607 619 98700 0.0012 0.62 Molecular rotor 9 683 706 128000 0.0005 0.39 Molecular rotor 12 646 667 130000 0.0046 0.55 Molecular rotor 19 730 750 100000 0.0001 0.15 Molecular rotor 40 689 711 100350 0.0024 0.50
[0421] Test Example 3
[0422] Molecular rotors 2, 9, 12, 19, and 40 were added to the ethylene glycol-glycerol mixed solution to prepare a final concentration of 1×10 -5 The solutions of M are excited at their respective optimal excitation wavelengths. The fluorescence emission spectra under different viscosity conditions are as follows: Figure 1 , 3 , 5, 7, and 9, the fluorescence intensity of the molecular rotors with the same concentration gradually increases under different viscosity conditions, indicating that the fluorescence intensity of the molecular rotors increases with the increase of the environmental viscosity. The relationship between the logarithm of the fluorescence intensity and the logarithm of the solvent viscosity conforms to the Huffman equation and has a good linear relationship, as shown in Figure 2 , 4 , 6, 8, and 10, which proves that the molecular rotor is sensitive to viscosity and can be used to test the viscosity of unknown samples.
[0423] Test Example 4
[0424] We used the fluorescence decay method to test the photostability of molecular rotors 6, 12, 20, 40, 42, and comparison molecules 1 and 2. We placed them on a confocal microscope, continuously irradiated the samples with a laser at the corresponding excitation wavelength, and recorded the changes in fluorescence intensity. The test results are shown in Figure 2. Fig.11As shown, the fluorescence intensity of the molecular rotor of the present invention decreases slightly with the extension of the illumination time, while the fluorescence intensity of the comparative molecules 1 and 2, which are considered to have good photostability, decreases significantly. This shows that the molecular rotor of the present invention has excellent photostability and is more suitable for long-term dynamic tracking and fluorescence imaging of biological substances.
[0425] Test Example 5
[0426] Molecular rotors 6, 12, 19, 20, 41, and reference molecules 3 and 4 were added to the ethylene glycol-glycerol mixed solution to prepare a final concentration of 1×10 -5 The solutions of M were excited at their respective optimal excitation wavelengths and the fluorescence lifetimes under different viscosity conditions were tested. The experimental results obtained by molecular rotors 6, 12, 19, 20, and 41 are shown in Fig.12 , Fig.13 , Fig.14 , Fig.15 , Fig.16 As shown in the figure, the fluorescence lifetime of molecular rotors of the same concentration increases with the increase of the viscosity of the microenvironment in which they are located, which indicates that the change of fluorescence lifetime can reflect the information of the microenvironment in which they are located, thereby realizing fluorescence lifetime imaging of biological molecules. In addition, the molecular rotor of the present invention has a long fluorescence lifetime and can obtain accurate test results in a solution with a lower viscosity (ethylene glycol), while the fluorescence lifetime of the traditional molecular rotor (comparative molecule 3) is short, and the fluorescence lifetime in a solution with a high viscosity such as glycerol is only about 0.1ns ( Fig.17 ), it is difficult to accurately detect in a low viscosity system and is not suitable for fluorescence lifetime imaging of biological substances. Furthermore, although the fluorescence lifetime of the comparative molecule 4 reaches the detectable range ( Fig.18 ), but its change in different viscosity environments is not obvious, so it is not suitable for fluorescence lifetime imaging of biological substances. The above shows that the molecular rotor fluorescent dye of the present invention has a long fluorescence lifetime and changes significantly with viscosity, and is more suitable for fluorescence lifetime imaging of biological substances.
[0427] Test Example 6
[0428] Molecular rotors 6, 12, 20, 40, 42, and control molecules 1 and 2 were added to the cell culture medium to a final concentration of 1×10 -6 M solution was used to culture Hela cells. After incubation for 2 h, the maximum excitation wavelength of each compound was used to excite them, and their fluorescence intensity was detected. The strongest fluorescence of all groups was taken as 100 to normalize each sample. Fig.19 The results show that the molecular rotor of the present invention has lower background fluorescence compared with dyes with similar structures (comparative molecules 1 and 2).
[0429] Test Example 7
[0430] Molecular rotors 34, 35, 39 and 40 can be specifically located in subcellular organelles (lysosomes, mitochondria, cell membranes and endoplasmic reticulum, etc.), and specific fluorescence imaging of subcellular organelles can be performed, such as Fig. 20 As shown. The dye only emits bright fluorescence at the location of the subcellular organelle, and the nonspecific fluorescence at other locations of the cell and the background fluorescence in the culture medium are very weak. This shows that the dye invented in this application has good cell membrane permeability, and after targeting the subcellular organelle, it can be activated by its microenvironment for fluorescence, and can be used for specific fluorescence imaging of subcellular organelles.
[0431] Test Example 8
[0432] Molecular rotors 22, 41 and 42 can specifically bind to protein tags Halo-Tag and SNAP-Tag. Before binding, the dyes basically do not fluoresce, but after binding, the fluorescence is significantly activated, such as Fig.21 As shown, cells expressing the tagged protein emit bright fluorescence, while cells not expressing the protein have no fluorescence, which indicates that the dyes of the present invention can be used to label proteins in living cells.
[0433] Test Example 9
[0434] Molecular rotors 5, 6, 12 and 19 can be used for the screening of nucleic acid aptamers, and the RNA aptamers screened can bind specifically, the dye background is very low before binding, and the fluorescence is significantly activated after binding, such as Fig. 22 As shown, the dye can also bind to the RNA aptamer in living cells to emit bright fluorescence, with basically no non-specific fluorescence activation, which shows that the dye of the present invention has very low background fluorescence and very low non-specific fluorescence in cells, and can be used to label low-abundance biomacromolecules such as nucleic acids. The sequence of one RNA aptamer is:
[0435] AGACGCAACUGAAUGAAACAUUCCCACCUUAGAGUGACUGUGCCUGCUUCGGCAGGACAGGUGCAUGUCAACCGCUGUCACUCCGUAACUAGUCGCGUCAC.
[0436] Test Example 10
[0437] Molecular rotors 35, 36, and 39 enable in vivo fluorescence imaging of tumors. Subcutaneous sarcomas were implanted in the legs of mice and dyes were injected intravenously. The experimental results are shown in Figure 2. Fig.23 As shown, the tumor site on the mouse leg exhibited obvious fluorescence signals, which indicated that the fluorescent dye of the present invention could be specifically enriched in the tumor site and exhibit strong fluorescence signals, and could be used for in vivo fluorescence imaging of tumors.
Claims
1. A fluorescent dye having a structure as shown in formula (I), in: A is -N(X1)(X2) or HO-, B is =N + (X3)(X4) or =O, or X1, X2 and R2 and / or R3, or X3, X4 and R4 and / or R5 are connected to form a heterocyclic group; X1, X2, X3, and X4 are each independently selected from at least one of hydrogen, alkyl, modified alkyl, aryl, heteroaryl, and unsaturated or saturated heterocyclic groups, or X1 and X2, or X3 and X4 are optionally connected to each other to form a saturated or unsaturated unsubstituted or R 1-1 substituted heterocyclic group or heteroaromatic ring, or X1, X2 and R2 and / or R3, or X3, X4 and R4 and / or R5 are optionally connected to each other to form a saturated or unsaturated unsubstituted or R 1-1 substituted heterocyclic group; and / or R1, R2, R3, R4, R5, R6 are optionally independently selected from hydrogen, a halogen atom, a nitro group, or an alkyl group; When K is selected from S, Se, Te, Te=O, unsubstituted or 1 or 2 R 1-1 Substituted carbon, unsubstituted or 1 or 2 R 1-1 Substituted germanium, (R0 are each independently selected from ), G is selected from the following formula (I-1-1), formula (I-1-2), formula (I-1-3) or formula (I-1-4); When K is selected from O or unsubstituted or 1 or 2 R 1-1 When the silicon is substituted and A is not -N(X1)(X2), G is selected from the following formula (I-1-1), formula (I-1-2), formula (I-1-3) or formula (I-1-4). When K is selected from O or unsubstituted or 1 or 2 R 1-1 Substituted silicon, when A is -N(X1)(X2) and B is =N+(X3)(X4), G is selected from the following formula (I-1-2) or formula (I-1-3); in, Each R 1-1 Each is independently selected from a halogen atom or an alkyl group; Each Y is independently selected from O, S, NH, Se, or Te; Each Z is independently selected from C, or N, Each R a , each R b , each R c Each is independently selected from hydrogen, sulfonic acid group, haloacyl group, cyano group, cyanate group, isothiocyanate group, carboxyl group, ester group, amide group, nitro group, halogen atom, alkyl group, haloalkyl group, modified alkyl group; The C ring in formula (I-1-2) and the E ring in formula (I-1-3) are each independently selected from at least one of an aromatic ring or an aromatic heterocyclic ring; Each hydrogen atom in formula (I-1-2) and formula (I-1-3) is optionally independently substituted by a halogen atom or an alkyl group; D in formula (I-1-2) and F in formula (I-1-3) are each independently selected from hydrogen, cyano, amino, isothiocyanate, carboxyl, sulfone, phosphite, ester, amide, nitro, halogen, alkyl, aryl, heteroaryl, or modified alkyl; in, The "alkyl" is C1-C 10 Straight or branched alkyl; preferably, C1-C7 straight or branched alkyl; preferably, C1-C5 straight or branched alkyl; preferably, selected from methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, isopentyl, 1-ethylpropyl, neopentyl, n-hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl ... hexyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,3-dimethylbutyl, 2-ethylbutyl, n-heptyl, 2-methylhexyl, 3-methylhexyl, 2,2-dimethylpentyl, 3,3-dimethylpentyl, 2,3-dimethylpentyl, 2,4-dimethylpentyl, 3-ethylpentyl or 2,2,3-trimethylbutyl; The "modified alkyl" is a group obtained by replacing any carbon atom of an alkyl group with at least one group selected from halogen atoms, -O-, -OH, -CO-, -NO2, -CN, -S-, -SO2-, -(S=O)-, an aryl group optionally substituted with a halogen atom, an amino group, a secondary amino group, a tertiary amino group, a heterocyclic group, a saturated or unsaturated monocyclic or heterocyclic group, and the modified alkyl group has 1 to 30 carbon atoms (preferably 1 to 20 carbon atoms, more preferably within 10 carbon atoms), and its carbon-carbon single bond is optionally and independently replaced by a carbon-carbon double bond or a carbon-carbon triple bond; The carbon atom is replaced, which means that the carbon atom or the carbon atom together with the hydrogen atoms thereon are replaced by the corresponding group; The "heterocyclic group" is a 4-10 membered monocyclic or polycyclic heterocyclic group containing at least one heteroatom selected from N, O, S or Si in the ring; The "aryl" or "aromatic ring" is a 5-10 membered monocyclic or fused bicyclic aromatic group; The "heteroaryl" or "aromatic heterocycle" is a 5-10 membered monocyclic or fused bicyclic heteroaromatic group containing at least one heteroatom selected from N, O, S or Si in the ring; The halogen atoms in the "halogen atom", "haloalkyl", "haloacyl" and "aryl substituted with halogen atom" are each independently selected from F, Cl, Br and I; The "ester group" is -(C=O)OR 1-2 Group; The "amide group" is -CONR 1-2 Group; The "sulfone group" is -SO2R 1-2 Group; The "sulfoxide"-SOR 1-2 Group; The "secondary amino group" is -NHR 1-2 Group; The "tertiary amino group" is -NR 1-2 R 1-3 Group; Each R 1-2 , R 1-3 Each is independently H, an alkyl group, a modified alkyl group or a halogen atom.
2. The fluorescent dye according to claim 1, characterized in that X1, X2 and R2 and / or R3 are optionally connected to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formula: X3, X4 and R4 and / or R5 are optionally connected to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formula: Preferably, the heterocyclic group formed by X1, X2 and R2 and / or R3 or X3, X4 and R4 and / or R5 is a symmetrical structure; Preferably, each R' is independently selected from hydrogen or alkyl; Preferably, X1 and X2 are optionally connected to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formulae, wherein the following groups are optionally substituted by halogen atoms; Preferably, X3 and X4 are optionally connected to each other to form a saturated or unsaturated heterocyclic group selected from any group of the following formulae, wherein the following groups are optionally substituted by halogen atoms; Preferably, the heterocyclic group composed of X1 and X2, X3 and X4 is a symmetrical structure; Preferably, K is selected from oxygen, sulfur, selenium, tellurium or the following groups: Preferably, formula (I-1-1) and (I-1-4) are selected from any of the following groups: Preferably, formula (I-1-2) can be selected from any of the following groups: Alternatively, formula (I-1-3) may be selected from any of the following groups:
3. The fluorescent dye according to claim 1 or 2, characterized in that The fluorescent dye is selected from the following compounds:
4. The method for preparing the fluorescent dye according to any one of claims 1 to 3, characterized in that: The method comprises reacting a brominated aromatic ring compound represented by formula (II-1-1), formula (II-1-2), formula (II-1-3) or formula (II-1-4) with a ketone represented by (II-2) to obtain a fluorescent dye represented by formula (I):
5. A fluorescence-activated biomaterial-specific labeling method, characterized in that: The method comprises the following steps: after the fluorescent dye described in any one of claims 1 to 3 is brought into contact with a biological substance (including protein, RNA or DNA), the fluorescent dye and the biological substance are covalently or non-covalently bound to each other, thereby specifically activating the fluorescence of the dye molecule and achieving specific fluorescent labeling of the biological substance; Optionally, the reaction medium of the labeling reaction is selected from a pure analyte solution (pure protein, pure DNA and RNA), a cell lysate or an in situ medium where the analyte is located; optionally, the in situ medium is an intracellular medium, an intracellular organelle medium, a living tissue medium, blood or a body fluid.
6. A probe kit, characterized in that A fluorescent dye comprising any one of claims 1 to 3; Optionally, the probe kit further comprises a biocompatible medium; optionally, the biocompatible medium is selected from at least one of dimethyl sulfoxide, a buffer, and physiological saline; optionally, the buffer comprises a phosphate buffer.
7. A pharmaceutical preparation, characterized in that A fluorescent dye comprising any one of claims 1 to 3; Optionally, the pharmaceutical preparation is a pharmaceutical composition prepared by mixing the fluorescent dye according to any one of claims 1 to 3 with other compounds and suitable for administration to animals or humans, and the pharmaceutical composition also includes a physiologically acceptable carrier for animals or humans. Optionally, physiologically acceptable carriers include water, saline, and may also include pharmaceutical agents such as buffers, and other pharmaceutical agents such as compatible preservatives used in pharmaceutical dosage forms; preferably the carrier is a liquid, more preferably an aqueous solution.
8. Use of the fluorescent dye according to any one of claims 1 to 3 in the preparation of a pharmaceutical preparation for in vitro disease detection.
9. The use according to claim 8, characterized in that The in vitro disease detection includes labeling fluorescent dye molecules on antibodies to detect diseases through antigen-antibody interaction; or using dye molecules as targets to screen nucleic acid aptamers, and using the screened aptamers to perform fluorescent imaging of target nucleic acids and as probes for the detection of various disease markers.
10. Use of the fluorescent dye according to any one of claims 1 to 3 in the preparation of an optical imaging system for in vivo fluorescence imaging detection or treatment; Optionally, the in vivo fluorescence imaging detection or treatment includes performing fluorescence-guided surgery or in vitro tissue staining on humans or animals by fluorescence imaging or fluorescence lifetime imaging; Optionally, the optical imaging system includes an imager or various optical fibers, laparoscopy, or endoscopes used in conjunction with fluorescence imaging of humans or animals.
Citation Information
Cited By
Method for fluorescently labeling protein
WO2026182091A1
